Section 35

EurekaMag PDF full texts Chapter 34,517


Jeng, A.Y.; Savage, P.; Beil, M.E.; Bruseo, C.W.; Hoyer, D.; Fink, C.A.; Trapani, A.J. 2002: CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 2411. Clinical Science (london). 103(suppl. 48): 98s-101s, Ust
Sakai, T.; Oga, N.; Tanaka, N.; Takahashi, M.; Miura, M.; Ema, T.; Korenaga, T. 2002: CGTase-catalyzed selective glucosidation of chiral alcohol. Journal of Molecular Catalysis B Enzymatic 18(1-3): 191-192, 13 September
Chou, H.A.; Ovadia, M.; Zavitz, D.H. 2000: CH3 11SAu self-assembled monolayer electrodes in living heart Electronic conduction at a capacitive interface. Biophysical Journal 78(1 Part 2): 223A
Butler, R.; Ritchie, B.; Tran, C.D.; Brewster, D.; Zacharakis, B.; Davidson, G. 2002: CH4 production Large differences in aboriginal vs caucasian infants. Gastroenterology 122(4 Suppl 1): A 545
LiTingTing; HuangYao; ZhangWen; SongChangChun 2010: CH4MODwetland a biogeophysical model for simulating methane emissions from natural wetlands. Ecological Modelling 1(4): 666-680
Lev, D.; Nakar, O.; Bar Am, I.; Watemberg, N.; Finkelstien, S.; Katzin, N.; Lerman Sagie, T. 1999: CHARGE association in a child with de novo chromosomal aberration 46XX, +der t detected by spectral karyotyping. European Journal of Human Genetics 7(Suppl 1): 75
Mackerell, Alexander, D.Jr 2002: CHARMM Biomolecular Force Field Recent developments and future directions. Abstracts of Papers American Chemical Society 224(1-2): COMP 10
Anisimov, V.M.; Vorobyov, I.V.; Lamoureux, G.; Noskov, S.; Roux, B.; Mackerell, A.D.J. 2004: CHARMM all-atom polarizable force field parameter development for nucleic acids. Biophysical Journal 86(1): 415a
Saunders, M.I.; Dische, S.; Rojas, A. 1999: CHART A tale of two disciplines. British Journal of Cancer 80(Suppl 1): 110-115
Dische, S.; Saunders, M.; Bentzen, S. 2000: CHART Implications for the treatment of head and neck cancer. Radiotherapy and Oncology 56(Suppl 1): S4
Lyn, B.E.; Wilson, E.M.; Williams, F.J.; Saunders, M.I.; Phillips, H. 2003: CHART to CHARTWEL to chemotherapy and CHARTWEL in non-small cell lung cancer. British Journal of Cancer 88(Suppl 1): S23
Jones, D.W.; Chambless, L.E.; Folsom, A.R.; Heiss, G.; Hutchinson, R.G.; Sharrett, R.A.; Szklo, M.; Tyroler, H.A.; Taylor, H.A.Jr 2001: CHD risk factors in African-Americans. Circulation 103(9): 1347
L'italien, G.J.; Koro, C.E.; Fedder, D.E. 2002: CHD risk factors predominate among African-American women versus men who are eligible for lipid-lowering drug therapy under the new ATPIII guidelines. Circulation 106(19): 2; 748
Wilson, P.W.F.; D'agostino, R.B.; Sullivan, L.; Vasan, R.S. 2002: CHD risk in persons with diabetes mellitus or with known coronary heart disease. Circulation 106(19): II509
Schuster, E.F.; Stöger, R. 2002: CHD5 defines a new subfamily of chromodomain-SWI2/SNF2-like helicases. Mammalian Genome: Official Journal of the International Mammalian Genome Society 13(2): 117-119
Nakano, H.; Uchida, O.; Koga, M.; Ohshima, Y. 2001: CHE-1, a zinc-finger transcriptional factor regulates expression of signaling molecules in ASE chemosensory neurons in C elegans. Development Growth and Differentiation 43(Suppl): S21
Tammela, T.L.J.; Seppala, E.H.; Ikonen, T.; Autio, V.; Mononen, N.; Rokman, A.; Matikainen, M.P.; Schleutker, J. 2004: CHEK2 and MSR1 genes in prostate cancer predisposition in Finnish population. Journal of Urology 171(4 Suppl): 108
Kilpivaara, O.; Bartkova, J.; Eerola, H.; Smitten, K.V.; Aittomki, K.; Blomqvist, C.; Sauter, G.; Kallioniemi, O.P.; Bartek, J.; Nevanlinna, H. 2003: CHEK2 and breast cancer A validation study in Finland and expression in unselected breast tumors by tissue microarray analysis. American Journal of Human Genetics 73(5): 236
Coupier, I.; Stoppa-Lyonnet, D. 2002: CHEK2 and breast cancer risk. Bulletin du Cancer 89(11): 921-922
Ohayon, T.; Gal, I.; Baruch, R.G.; Szabo, C.; Friedman, E. 2004: CHEK2*1100delC and male breast cancer risk in Israel. International Journal of Cancer 108(3): 479-480
Pereira, L.H.M.; Sigurdson, A.J.; Doody, M.M.; Pineda, M.A.; Alexander, B.H.; Greene, M.H.; Struewing, J.P. 2003: CHEK21100delC mutation and elevated breast cancer risk. American Journal of Human Genetics 73(5): 256
Anonymous 2003: CHEST 2003, Orlando, FL, USA, October 25-30, 2003. Chest 124(4 Suppl): 69S-345S
Moncher, K.; Akosah, K.; Schaper, A.; Havlik, P.; Sundaram, R.; Devine, S. 2000: CHF in the community Missed diagnosis and missed opportunities. Chest 118(4 Suppl): 220S
Jaber, W.A.; Prior, D.L.; Marso, S.P.; Houghtaling, P.L.; Menon, V.; Harrington, R.A. 1999: CHF on presentation is associated with markedly worse outcomes among patients with acute coronary syndrome PURSUIT trial findings. Circulation 100(18): 1; 433
Latini, R.; Anand, I.; Masson, S.; Judd, D.; Salio, M.; Baldi, G.; Glazer, R.; Spormann, D.P.; Maggioni, A.P.; Tognoni, G.; Cohn, J.N. 2001: CHF severity and neurohormonal activation in a large international population with chronic heart failure enrolled in Val-HeFT. Journal of the American College of Cardiology 37(2 Suppl A): 148A
Shi, Y.F.; Li, D.; Tardif, J.C. 1999: CHF-induced atrial abnormalities and atrial fibrillation. Circulation 100(18): 1; 237
Trabace, L.; Cassano, T.; Loverre, A.; Steardo, L.; Cuomo, V. 2002: CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor. Cns Drug Reviews 8(1): 53-69
Erson, A.E.; Petty, E.M. 2003: CHFR associated G2/M checkpoint defects in breast cancer Functional implications for tumorigenesis. Proceedings of the American Association for Cancer Research Annual Meeting 44: 19
Shilenkova, V.I. 2003: CHICCO firm production Ideal choice for breat-fed woman and her baby. Pediatriya (Moscow) (4): 87-88
Grzeschik, K.H.; Koenig, A.; Bornholdt, D.; Engel, H.; Happle, R. 2001: CHILD syndrome Molecular and functional analysis. American Journal of Human Genetics 69(4 Suppl): 618
Grzeschik, K.H.; Bornholdt, D.; Koenig, A.; Engel, H.; Happle, R. 2001: CHILD syndrome, a lateralized developmental malformation caused by a defect in cholesterol biosynthesis. Development Growth and Differentiation 43(Suppl): S20
Grzeschik, K.; Bornholdt, D.; Koenig, A.; Engel, H.; Happle, R. 2001: CHILD syndrome; molecular analysis. European Journal of Human Genetics 9(Suppl 1): P0574
Xu, W.; Mimnaugh, E.; Patterson, C.; Neckers, L.M. 2001: CHIP, a TPR domain and U-box containing protein, binds to and down-regulates ErbB2 protein in transfected cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 935-936
Peralta, N.; Koerner, C.E. 1999: CHIPS Teaching safety to children ages four through eight years old by video. Journal of Investigative Medicine 47(2): 112A
Tort, F.; Hernandez, S.; Sanchez, M.; Campo, E. 2003: CHK1 gene status and mRNA and protein expression in human lymphoid neoplasms. Proceedings of the American Association for Cancer Research Annual Meeting 44: 17-18
Rahman, N.; Meijers Heijboer, H.; Schutte, M.; Sodha, N.; Easton, D.F.; M.R. Stratton And Breast Cancer Linkage Consortium 2002: CHK2 1100delC is a low penetrance breast cancer susceptibility allele in non-carriers of BRCA1 or BRCA2 mutations. European Journal of Human Genetics 10(Suppl 1): 69
Vahteristo, P.; Bartek, J.; Bartkova, J.; Ojala, S.; Eerola, H.; Kononen, J.; Heikkila, P.; Kallioniemi, O.P.; Nevanlinna, H. 2001: CHK2 in familial breast cancer. American Journal of Human Genetics 69(4 Suppl): 256
Warner, T.G.; Sliwkowski, M.B. 1999: CHO cell sialidase by recombinant DNA technology. Official Gazette of the United States Patent and Trademark Office Patents 1224(4)
Rowe, P.S.N.; Kumagai, Y.; Garrett, R.; Blacher, R.; Escobada, A.; Mundy, G.R. 2002: CHO-cells expressing MEPE, PHEX and co-expressing MEPE/PHEX cause major changes in BMD, Pi and serum alkaline phosphatase in nude mice. Journal of Bone and Mineral Research 17(Suppl 1): S211
Eddes, J.S.; Kapp, E.A.; Frecklington, D.F.; Moritz, R.L.; Simpson, R.J. 2003: CHOMPER A bioinformatic tool for rapid visualisation and validation of SEQUEST and MASCOT MS/MS search results. Molecular and Cellular Proteomics 2(9): 829
Boue, F.; Gabarre, J.; Gisselbrecht, C.; Reynes, J.; Plantier, I.; Morlat, P.; Milpied, N.; Raphael, M.; Lancar, R.; Costagliola, D. 2002: CHOP Chemotherapy Plus Rituximab in HIV Patients with High Grade Lymphoma - Results of an ANRS Trial. Blood 100(11): Abstract No. 1824
Miller, T.P.; Leblanc, M.; Spier, C.; Chase, E.; Fischer, R.I. 2001: CHOP alone compared to CHOP plus radiotherapy for early stage aggressive Non-Hodgkins lymphomas Update of the Southwest Oncology Group randomized trial. Blood 98(11 Part 1): 724a-725a
Press, O.W.; Unger, J.M.; Braziel, R.M.; Maloney, D.M.; Miller, T.P.; Leblanc, M.; Fisher, R.I. 2003: CHOP followed by Tositumomab/Iodine I 131 Tositumomab for treatment of newly diagnosed follicular non-Hodgkins lymphomas A phase II trial of the Southwest Oncology Group. Blood 102(11): 29a
Czuczman, M.S. 1999: CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma. Seminars in Oncology 26(5 Suppl 14: 88-96
Birhiray, R.; Rudolf, D.; Trynoski, S.; Hocking, W.; Spindler, M.; Krawitz, B. 2000: CHOP, rituximab and intron A as initial therapy for follicular lymphomas. Blood 96(11 Part 2): 234b-235b
Jaeger, G.; Brezinschek, R.; Neumeister, P.; Linkesch, W. 2000: CHOP-induction and anti-CD20- consolidation as first-line treatment of follicular lymphoma Preliminary data of a phase II study. Onkologie 23(Sonderheft 7): 151
Chakrabarti, E.; Kawamura, H.; Maytin, E.V. 2003: CHOP/gadd153 expression, caspase-3 activation, and sunburn cell formation are up-regulated concurrently following UVB irradiation of murine skin. Journal of Investigative Dermatology 121(1): 1125
James, J.L.; Thomas, P.; Cavan, D.A.; Kerr, D. 2003: CHOPPS The christchurch obesity prevention programme in schools. Diabetologia 46(Suppl 2): A86
Scolnick, D.M.; Krantz, I.; Halazonetis, T.D. 1999: CHRF prevents chromosomal condensation in response to a defective spindle. Proceedings of the American Association for Cancer Research Annual Meeting 40: 215
Lee Jeong, H. Cho Hye, S. Kim, D.M.; Pai Hyun, S. Lim Yong, P. Kim Youn Sung 2002: CHRK1, a chitinase-related receptor-like kinase regulates cell division and differentiation, and infulences cytokinin response in tobacco. Plant Biology (Rockville) : 177
Bonati, M.T.; Asselta, R.; Duga, S.; Malcovati, M.; Tenchini, M.L.; Oldani, A.; Zucconi, M.; Ferini Strambi, L.; Dalpra', L. 2000: CHRNA3/CHRNA5/CHRNB4 cluster and autosomal dominant nocturnal frontal lobe epilepsy. European Journal of Human Genetics 8(Suppl 1): 142-143
Bramm, E.; Hjarnaa, P.V.; Latini, S.; Skov, T.; Dahr, S.; Larsson, R.; Binderup, L. 1999: CHS 828 A novel cyanoguanidine antitumor agent with potent oral activity. Proceedings of the American Association for Cancer Research Annual Meeting 40: 299
Aleskog, A.; Jonsson, E.; Hassan, S.; Binderup, L.; Larsson, R.; Kristensen, J. 1999: CHS 828 A novel cyanoguanidine with potent cytotoxic activity in primary cultures of human tumor cells. Proceedings of the American Association for Cancer Research Annual Meeting 40: 299
Liminga, G.; Martinsson, P.; Jonsson, E.; Nilsson, K.; Bramm, E.; Kristensen, J.; Binderup, L.; Larsson, R. 1999: CHS 828 actions in a human tumor lymphoma cell line Measurements of macromolecular synthesis, membrane integrity, metabolism and apoptosis. Proceedings of the American Association for Cancer Research Annual Meeting 40: 1-2
E.K.atib, M.T.; Kant, S.; Dancan, H. 2003: CHr, CRP and erythropoietin resistance in dialysis patients. Journal of the American Society of Nephrology 14(Abstracts Issue): 708A
Taub, E.; Pidikiti, R.D.; Chatterjee, A.; Uswatte, G.; King, D.K.; Bryson, C.; Willcutt, C.; Jannett, T.; Yakley, S.; Spear, M. 1999: CI Therapy extended from upper to lower extremity in stroke patients. Society for Neuroscience Abstracts 25(1-2): 320
Losa, M.; Frey, B.; Zimmermann, K. 2001: CI vs CI. Swiss Medical Weekly 131(11-12): 166
Baxi, S.M.; Chesebro, J.H.; Fitzgerald, G.; Peng, Y.W.; Dombi, T.; Leadley, R.J.J. 2003: CI-1031 , a direct FXa inhibitor, decreases thrombin generation in Badimon Chamber studies in human patients. Blood 102(11): 813a
Allen, A.M.; Ethier, S.P. 2003: CI-1033 a pan Erb-B family tyrosine kinase inhibitor induces apoptosis in radiosenstization in human glioblastoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 890
Ethier, S.P.; Allen, A.M. 2003: CI-1033 an pan Erb-b tyrosine kinase inhibitor induces apoptosis and radiosensitization in human glioblastoma cells. International Journal of Radiation Oncology Biology Physics 57(2 Suppl): S295
Kamat, A.M.; Kedar, D.; Bermejo, C.; Davis, D.; Radinsky, R.; Elliott, W.; Bar Eli, M.; Mcconkey, D.; Dinney, C. 2003: CI-1033, a pan-erbB tyrosine kinase antagonist, inhibits the growth of orthotopic bladder cancer tumors via direct effects on receptor phosphorylation and inhibition of angiogenesis. Journal of Urology 169(4 Suppl): 130-131
Slichenmyer, W.J.; Elliott, W.L.; Fry, D.W. 2001: CI-1033, a pan-erbB tyrosine kinase inhibitor. Seminars in Oncology 28(5 Suppl 16: 80-85
Allen, L.F.; Eiseman, I.A.; Fry, D.W.; Lenehan, P.F. 2003: CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer. Seminars in Oncology 30(5 Suppl 16: 65-78
Allen, L.F.; Sebolt Leopold, J.; Meyer, M.B. 2003: CI-1040 , a targeted signal transduction inhibitor of MEK. Seminars in Oncology 30(5 Suppl 16): 105-116
Anonymous 2000: CI-994 Oncolytic EN 137584. Drugs of the Future 25(11): 1182
Tang, N.; Yang, J.; Lin, T.; Foskett, J.K.; Ostap, E.M. 2004: CIB and CaBP-1 bind to the IQ domains of myo1c. Biophysical Journal 86(1): 571a
Yuan, W.; Mcfadden, A.W.; Wang, Z.; Larson, M.K.; Boudignon Proudhon, C.; Parise, L.V. 2003: CIB is an endogenous inhibitor of inside-out integrin alphaIIbbeta3 activation in primary murine megakaryocytes. Blood 102(11): 160a
Menna Barreto, L.; Lopes, J.R.; Diambra, L. 2001: CICLOGRAMA A tool for the analysis of polyphasic sleep. Chronobiology International 18(6): 1164-1165
Stice, S.L.; Cibelli, J.; Robl, J.; Golueke, P.; Ponce, D.L., F.A.; Jerry, D.J. 2001: CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus. Official Gazette of the United States Patent and Trademark Office Patents 1246(4)
Vallat, J.M.; Tabaraud, F.; Magy, L.; Kpade, C.; Sindou, P.; Torny, F.; Couratier, P. 2002: CIDP revisited Discussion of the diagnostic criteria. Neurology 58(7 Suppl 3): A302-A303
Colazo, M.G.; Kastelic, J.P.; Whittaker, P.R.; Mapletoft, R.J. 2003: CIDR-based protocols for synchronizing bovine embryo transfer recipients without estrus detection. Journal of Dairy Science 86(Suppl 1): 183-184
Merli, F.; Bertini, M.; Luminari, S.; Botto, B.; Tarantini, G.; Freilone, R.; Berte, R.; Liberati, A.M.; Malorgio, F.; Gallo, E.; Gugliotta, L. 2002: CIEP An Oral Chemotherapy Regimen Devised for Diffuse Large Cell Lymphoma in Elderly Patients An Interim Report from Italian Lymphoma Intergroup. Blood 100(11): Abstract No. 4725
Rausch, T.; Grsic Rausch, S.; Eufinger, J.; Grunze, N.; Steininger, H.; Carlson, S.; Chourey, P. 2002: CIF/VIF-related proteins in maize Probing the function and localization of invertase inhibitor homologs. Plant Biology (Rockville) : 164
Kaufmann, J. 2003: CIF130 inhibits cell cycle progression. Official Gazette of the United States Patent and Trademark Office Patents 1272(2)
Kaufmann, J. 2001: CIF150/hTAFII150 is necessary for cell cycle progression. Official Gazette of the United States Patent and Trademark Office Patents 1242(3)
Landmann, S.; Waldburger, J.M.; Masternak, K.; Muhlethaler Mottet, A.; Reith, W. 2003: CIITA and the MHCII enhanceosome in the regulation of MHCII expression. Current Genomics 4(4): 343-363
Accolla, R.S.; Mazza, S.; De Lerma Barbaro, A.; Tosi, G. 2002: CIITA blocks the function of HIV-1 Tat by competing for cyclin T1 and inhibits viral replication. Tissue Antigens 59(2 Suppl): 68
Nagarajan, U.M.; Nilsen, R.; Lochamy, J.; Rudy, C.; Chen, X.; Jensen, P.; Boss, J. 2001: CIITA is required for maximal expression of HLA-DOB. FASEB Journal 15(4): A694
Barbaro, A.D.L.rma; Tosi, G.; Frumento, G.; Bruschi, E.; D'agostino, A.; Valle, M.T.; Manca, F.; Accolla, R.S. 2000: CIITA reduced transcription as the cause of HLA class II down-modulation in human macrophages during bacterial phagocytosis. FASEB Journal 14(6): A1027
Glimcher, L.H.; Zhou, H.Y.n 2002: CIITA-interacting proteins and methods of use therefor. Official Gazette of the United States Patent and Trademark Office Patents 1259(4)
Sisk, T.J.; Roys, S.; Chang, C.H. 1999: CIITA-p300 complex mediated transcriptional activation and repression. FASEB Journal 13(5 Part 2): A650
Andersen, E.Sogaard 2002: CIN Which lesions should be treated and how. International Journal of Cancer Suppl (13): 9
Santos, C. 2002: CIN management in developing countries. International Journal of Cancer Suppl (13): 67
A.N.fussi, A.I.; Monaghan, H. 2000: CIN3-like carcinoma of cervix An unrecognized subtype of invasive squamous carcinoma. Journal of Pathology 190(Suppl): 36A
Anthony, D.C.; Campbell, S.J.; Perry, V.H. 2003: CINC-1 is an early hepatic acute phase protein induced by focal brain injury that causes leukocyte mobilization and liver injury. Journal of Neurochemistry 87(Suppl 1): 9
Kittisarapong, K.; Thavonpanich, N.; Benjapolpitak, S.; Basile, G. 2004: CINCA syndrome A case report of a superficial resemblance to systemic-onset JRA with mutation in CIAS 1 gene from Thailand. Journal of Allergy and Clinical Immunology 113(2 Suppl): S132
Tsintis, P.; La Mache, E. 2004: CIOMS and ICH initiatives in pharmacovigilance and risk management: overview and implications. Drug Safety 27(8): 509-517
Sasaki, I.; Naito, H.; Funayama, Y.; Fukushima, K.; Shibata, C.; Katsuno, S.; Fukudo, S.; Hongo, M. 1999: CIP after cholecystectomy in patients with massive small bowel resection Is it a new clinical entity?. Gastroenterology 116(4 Part 2): A925
Althuisius, S.; Dekker, G.; Hummel, P.; Bekedam, D.; Van Geijn, H. 2001: CIPRACT Therapeutic cerclage with bed rest versus bed rest, final results. American Journal of Obstetrics and Gynecology 184(1): S2
Schumann, W. 2001: CIRCE, HAIR and ROSE Regulation of the bacterial heat shock response. Biology International 40: 3-5
Michael, J.A.; Rovick, A.A.; Evens, M.; Glass, M.; Zhou, Y. 1999: CIRCSIM-TUTOR A smart tutor about blood pressure regulation. American Journal of Physiology 277(6 part 2): S153
Salam, S.E.A.del; Moto, K.; Sakurai, S.; Iwami, M. 2000: CIS element responsible for the cell-specific expression of bombyxin F1 gene in the brain of the silkworm Bombyx mori. Zoological Science 17: 24
Berry, S.A.; Haubein, L.S.; Towle, H.C. 2003: CIS expression inhibits growth hormone responsive gene expression in inflammation via NFkappaB. Pediatric Research 53(4 Part 2): 149A
Prathikanti, S.; Akula, N.; Mcmahon, F.J. 2002: CIS-4 A positional candidate gene for bipolar affective disorder on chromosome 18q22. American Journal of Medical Genetics 114(7): 804-805
Carmichael, G.G.; Huang, Y. 1999: CIS-acting cellular nucleic acid molecules. Official Gazette of the United States Patent and Trademark Office Patents 1228(4)
Bilous, M.; Morey, A.; Armes, J.; Cummings, M.; Francis, G. 2004: CISH or FISH? The interlaboratory reproducibility of CISH testing for HER2 and correlation with IHC and FISH results. EJC Suppls 2(3): 100-101
Aljundi, R.T.; Thomas, D.; Lizyness, M.; Kuick, R.; Misek, D.; Smith, A.; Sanders, D.; Gauger, P.; Thompson, N.; Taylor, J.; Shioda, T.; Hanash, S.; Giordano, T. 2003: CITED1, a potential new marker for papillary thyroid carcinoma Discovery by DNA microarray analysis and evaluation by tissue microarray immunohistochemistry. Modern Pathology 16(1): 102A
D.C.estecker, M.P.; Plisov, S.; Michael, T.; Genbin, S.; Yoshino, K.; Dawid, I.; Roberts, A.B.; Perantoni, A. 2001: CITED1/MSG1 is a bi-functional transcriptional gatekeeper that regulates epithelial morphogenesis in the developing kidney. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 519A
Chou, Y.T.; Yang, Y.C. 2003: CITED2 is a transcriptional modulator in TGF-beta signaling pathway. Blood 102(11): 835a
Capra, V.; De Marco, P.; Moroni, A.; Merello, E.; Raso, A.; Dunwoodie, S.; Cama, A. 2002: CITED2 is not a major determinant of human NTDs. American Journal of Human Genetics 71(4 Suppl): 468
Shen, Z.; Tsuji, K.; Nakamoto, T.; Hirai, H.; Nifuji, A.; Noda, M. 2001: CIZ, a transcription factor shuttling between nuclei and cell adhesion plaque, enhances Cbfa1 gene expression but counteracts against BMP signaling to resume osteopontin and to suppress collagen gene expression in osteoblast like cells. Journal of Bone and Mineral Research 16(Suppl 1): S174
Murad, A.M.; Lee, P.R.; Broadbent, I.D.; Barelle, C.J.; Brown, A.J. 2000: CIp10, an efficient and convenient integrating vector for Candida albicans. Yeast 16(4): 325-327
Padfield, A. 2002: CJ Massey Dawkins Pioneer epiduralist. Diz, Jose Carlos , Reprint Author, Franco, Avelino, Bacon, Douglas R, Rupreht, Joseph, Alvarez, Julian The history of anesthesia: 309-311
Cho, I.H.; Park, H.J.; Kim, T.; Jung, S.H.; Kim, I.H.; Lee, S.H.; Park, J.E.; Ryu, H.C.; Ko, D.H.; Kim, Y.J.; Yeon, K.J.; Chung, Y.M.; Chae, M.Y.; Lee, 2003: CJ-11668, a new potent COX-2 inhibitor Long-acting biological profile. Inflammation Research 52(Suppl 2): S 158
Lee, J.H.; Kim, H.W.; Kim, Y.H.; Park, S.W.; Noh, J.Y.; Kim, J.; Chun, H.O.; Choi, J.M.; Cho, I.H.; Lee, J.Y. 2003: CJ-11668, a new potent COX-2 inhibitor The anti-inflammatory effect in adjuvant-induced arthritis models. Inflammation Research 52(Suppl 2): S 158
Lawrence, B.; Dreyfus, J.; Wen, S.; Guivarc'h, P.; Drucker, D.; Castaigne, J.P.ul 2003: CJC-1131, a long acting GLP-1 derivative, exhibits an extended pharmacokinetic profile in healthy human volunteers. Diabetes 52(Suppl 1): A125
Wen, S.; Wilson, S.; Trebec, D.; Pham, K.; Castaigne, J.; Lawrence, B. 2003: CJC-1131, a long-acting GLP-1 analogue, exhibits safety and tolerability in dogs. Toxicological Sciences 72(S-1): 48
Lawrence, B.; Wen, S.; Dunn, D.; Iordanova, V.; Castaigne, J. 2003: CJC-1131, a long-acting GLP-1 analogue, is well tolerated in rats up to 14 days. Toxicological Sciences 72(S-1): 49
Guivarc'h, P.H.; Castaigne, J.P.; Dreyfus, J.F.; Wen, S.; Drucker, D.J. 2003: CJC-1131, a novel GLP-1 analogue with prolonged activity Initial clinical and pharmacokinetic observations. Diabetes and Metabolism 29(Hors serie 2): 4S123
Tullo, A.; Buckley, R.; Painter, M. 2000: CJD and the eye. Eye 14: 259-260
Chunhua, L.; Kim, H.; Liu, Y.; Medellin, D.M.; Brown, P. 2002: CJun-dominant-negative mutant inhibits breast cancer cell growth by inactivating critical cJun partners. Proceedings of the American Association for Cancer Research Annual Meeting 43: 546
Orellana, R.; Bella, M.; Gimenez, G.; Marques, G.; Simo, J.; Zidan, A.; Musulen, E.; Maurici, D.; Combalia, N.; Rey, M. 2003: CK-19, galectin-3, involucrin, p27 and Mib-1 expression in thyroid cells obtained by fine-needle aspiration citology and their histological counterparts A preliminary report. Virchows Archiv 443(3): 449
Goth, L.; Bigler, W.N. 2003: CK-2 antibody recognises cancer associated ectopic form of CK-2. Clinica Chimica Acta 329(1-2): 153-155
Lauwers, G.Y.; Mino, M.; Ban, S.; Sevestre, H. 2003: CK-7, CK-20 and mucin gene expression in gastric inlet patch. Modern Pathology 16(1): 125A-126A
Todorova, B.; Alabakovska Sonja, B.S.; Labudovik, D.D. 1999: CK-BB isoenzyme activity in asphyxiated full-term newborns depending on the stage of postasphyxiated encephalopathy. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S476
Heimann, R.; Goossens, A. 2004: CK19 is present in fetal thyroid tissue. Histopathology 45(3): 306-307
Guerra, B.; Boldyreff, B.; Sarno, S.; Cesaro, L.; Issinger, O.G.; Pinna, L.A. 1999: CK2: a protein kinase in need of control. Pharmacology and Therapeutics 82(2-3): 303-313
Cala, S.E.; Ram, M.L.; Kiarash, A.; Houle, T.D. 2002: CK2 phosphorylation of calsequestrin alters its ER localization. Molecular Biology of the Cell 13(Suppl): 261a-262a
Kohlstedt, K.; Mueller Esterl, W.; Busse, R.; Fleming, I. 2002: CK2 regulates the phosphorylation and secretion of the angiotensin converting enzyme in endothelial cells. Pfluegers Archiv European Journal of Physiology 443(Suppl 1): S194
Wu, S.L.; Khotari, P.; Wheeler, T.; Reese, T.; Connelly, J. 2001: CK7 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Laboratory Investigation 81(1): 128A
Regauer, S.; Mannweiler, S.; Beham, A. 1999: CK7-positive oropharyngeal squamous cell carcinomas and cystic metastases. Virchows Archiv 435(3): 168
Fitzpatrick, P.M.; Goalen, M.J.; Haley, W.E. 2003: CKD clinic improves outcomes. Journal of the American Society of Nephrology 14(Abstracts Issue): 788A
Singh, A.K.; Chuang, P. 2003: CKD practice patterns among general internists reflects a lack of awareness regarding referral criteria and renal clinical guidelines. Journal of the American Society of Nephrology 14(Abstracts Issue): 446A
Ahn, S.K.; Kim, J.K.; Hong, C.I. 2000: CKD-602 Oncolytic, DNA topoisomerase I inhibitor. Drugs of the Future 25(12): 1243-1246
Kara, I.O.; Erdogan, S.; Sahin, B.; Ergin, M.; Gonlusen, G.; Paydas, S. 2003: CKIT expression in adult primitive neuroectodermal tumor and Ewings sarcoma A retrospective immunohistochemical Study. EJC Suppls 1(5): S249
Blankenship, J.C.; Godfrey, N.K.; Balog, C.; Demko, S.L.; Califf, R.M.; Lincoff, A.M.; Tcheng, J.E.; Topol, E.J. 1999: CKMB enzyme rise after in-lab adverse events during coronary intervention in EPISTENT. Journal of the American College of Cardiology 33(2 Suppl A): 26A
Cinti, S.; Cancello, R.; Zingaretti, M.C.; Ceresi, E.; De Matteis, R.; Giordano, A.; Himms Hagen, J.; Ricquier, D. 2001: CL 316,243 and cold stress induce heterogeneous expression of mRNA and protein in rodent brown adipocytes. International Journal of Obesity 25(Suppl 2): S141
Wittendorp, M.C.; Biber, K.; Boddeke, H.W.G.M. 2004: CL-IB-MECA induced release of CCL2 by astrocytes possible role for the adenosine A3 receptor?. Naunyn-Schmiedeberg's Archives of Pharmacology 369(Suppl 1): R178
Zisman, A.; Pantuck, A.J.; Patel, B.J.; Tso, C.L.; Belldegrun, A.S. 2000: CL1-GFP A novel hormone refractory and metastatic prostate cancer model tagged with green fluorescence. Journal of Urology 163(4 Suppl): 102
Kamphuis, M.M.J.W.; Lejeune, M.P.G.M.; Westerterp Plantenga, M.S. 2002: CLA affects resting metabolic rate, fat free mass and appetite, but not body weight regain, fat mass or energy intake. International Journal of Obesity 26(Suppl 1): S45
Millis, J.R. 2000: CLA esters and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1239(4)
Kemp, A.S.; Campbell, D.E. 1999: CLA expression in non-atopic children and children with atopic dermatitis. Journal of Allergy and Clinical Immunology 103(1 Part 2): S215
Bougnoux, P.; Lavillonniere, F.; Garaud, P.; Jourdan, M.L.; Sebedio, J.L.; Chajes, V. 2001: CLA in breast cancer presentation and evolution. Proceedings of the American Association for Cancer Research Annual Meeting 42: 311
Lu, M.; Shi, L.; Belury, M.A. 2000: CLA induction of hepatic gene expression is dependent on phosphorylation. FASEB Journal 14(4): A207
Ohtsu, H.; Huang, V.; Bray, T.M. 2002: CLA inhibits prostate tumor cell growth and modulates expression of oxidative stress transcription factors. Free Radical Biology and Medicine 33(Suppl 2): S442-S443
Butz, D.E.; Cook, M.E. 2002: CLA modulates immune induced cachexia after immunization with arthritogenic collagen type II. FASEB Journal 16(5): A985
Liu, K.L.; Heuvel, J.P.V.nden; Watts, J.; Fischer, S.M.; Belury, M.A. 1999: CLA modulates phorbol ester induced PPAR-beta mRNA in mouse skin. Proceedings of the American Association for Cancer Research Annual Meeting 40: 362
Mahon, A.K.; Shi, L.; Belury, M.A. 2000: CLA supplementation in subjects with impaired glucose tolerance and Type 2 diabetes mellitus. FASEB Journal 14(4): A736
Loscher, C.; Mills, K.; Gibney, M.; Roche, H. 2004: CLA suppresses IL-12 and enhances IL-10 production in murine bone marrow derived dendritic cells. FASEB Journal 18(4-5): Abstract 133
Kupper, T.; Robert, C.; Fuhlbrigge, R.; Von Andrian, U. 1999: CLA+ T cells and blood DC scan cutaneous microvessels in normal skin Evidence for innate immunosurveillance. Journal of Investigative Dermatology 112(4): 555
Barclay, S.; Rakowski, K.P.; Taran, V. 2003: CLA-esters. Official Gazette of the United States Patent and Trademark Office Patents 1272(5)
Szelenyi, H.; Thiel, E.; Keilholz, U. 2000: CLAD in patients with multiple myeloma. Onkologie 23(Sonderheft 7): 105
Bryborn, M.; Halldén, C.; Säll, T.; Cardell, L.O. 2010: CLC- a novel susceptibility gene for allergic rhinitis?. Allergy 65(2): 220-228
Estévez, Rúl.; Jentsch, T.J. 2002: CLC chloride channels: correlating structure with function. Current Opinion in Structural Biology 12(4): 531-539
Jentsch, T.J. 2003: CLC chloride channels Structure, function, and dysfunction. Journal of General Physiology 122(1): 1a
Enz, R.; Cutting, G.R. 1999: CLC-2 is expressed in rod bipolar cells of the rat retina. IOVS Investigative Ophthalmology and Visual Science 40(4): S443
Robinson, N.C.; Nelson, D.J. 2003: CLC-3 activation by CaMKII-dependent phosphorylation in HT29 cells. Journal of General Physiology 122(1): 21a
Okabe, K.; Okamoto, F.; Kajiya, H.; Tuzuki, T.; Notoya, K.; Mikuni Takagaki, Y.; Soeda, H.; Miyauchi, A. 2000: CLC-3 chloride channels function of mechanosensing molecule in stretched rat osteocytes. Journal of Bone and Mineral Research 15(Suppl 1): S248
Hayama, A.; Uchida, S.; Sasaki, S.; Marumo, F. 2001: CLC-K2 chloride channel interacts with proteasome activator PA28 alpha. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 31A
Li, X.; Sossey Alaoui, K.; Head, K.; Asch, H.L.; Cowell, J.K. 2003: CLCA2, a Ca2+-activated Cl- channel, is mutated and down regulated in breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1214
Gruber, A.D.; Pauli, B.U. 1999: CLCA3 is a secreted, truncated member of the human family of calcium-activated chloride channels. FASEB Journal 13(4 Part 1): A71
Frattini, A.; Pangrazio, A.; Susani, L.; Sobacchi, C.; Mirolo, M.; Vezzoni, P.; Villa, A. 2003: CLCN7 mutations cause a broad spectrum of bone defects. Calcified Tissue International 72(3): 258
Sun, L.; Sun, T.T.; Lavker, R.M. 2000: CLED A novel Ca2+-binding protein associated with early keratinocyte differentiation. Journal of Investigative Dermatology 114(4): 816
Strange, K. 2003: CLH-3, a ClC anion channel activated during oocyte meiotic maturation in C elegans. Journal of General Physiology 122(1): 4a
Gagnon, M.; Whalen, R. 2000: CLIA policy on new laboratory instruments. Diagnostic Cytopathology 23(6): 435
Edwards, J.C. 2003: CLIC-1 chloride channel is expressed in the apical domain of proximal tubule and other absorptive epithelia, where it resides in vesicles along the endocytic pathway. Journal of the American Society of Nephrology 14(Abstracts Issue): 312A
Berryman, M.A.; Goldenring, J.R. 2002: CLIC4 colocalizes with AKAP350 at the tight junction, centrosome, and midbody in polarized JEG-3 choriocarcinoma cells. Molecular Biology of the Cell 13(Suppl): 169a-170a
Suh, K.S.; Fernandez Salas, E.; Edwards, L.E.; Hayes, D.D.; Marin, K.G.; Crutchley, J.M.; Cheng, C.; Yuspa, S.H. 2004: CLIC4/mtCLIC, a p53-regulated organellar chloride channel protein, translocates to the nucleus following apoptotic stimuli and alters nuclear chloride content and pH. Toxicologic Pathology 32(1): 157-158
Maemura, Koji; De La Monte, Suzanne M.; Chin, Michael T.; Layne, Matthew D.; Hsieh, Chung Ming; Fukumoto, Shinya; Watanabe, Masafumi; Yet, Shaw Fang; Perrella, Mark A.; Lee, Mu En 2000: CLIF, a novel cycle like factor regulates circadian plasminogen activator inhibitor-1 gene expression. Circulation 102(18): 2; 47
D'arnore, P. 2001: CLINICAL performance of the Sure-Vue hCG test with special emphasis on the hook effect. Clinical Chemistry 47(S6): A151
Chamuleau, Martine E.D.; Westers, Theresia M.; Van Ham, Marieke S.M.; Zevenbergen, Adri; Souwer, Yuri; Ossenkoppele, Gert J.; De Loosdrecht, Arjan A. Van 2002: CLIP Expression Diminishes the Immunogenicity of AML Blasts. Blood 100(11): Abstract No. 2165
Hoogenraad, C.C.; Eussen, B.; Grosveld, F.G.; Galjart, N.; De Zeeuw, C.I. 1999: CLIP-115 mediates the localization of dendritic lamellar bodies and is encoded by the CYLN2 gene, which maps to the Williams Syndrome critical region. European Journal of Morphology 37(4-5): 273
Fujikura, D.; Ito, M.; Uede, T.; Miyazaki, T. 2004: CLIPR-59 regulates NF-kappa B activation mediated by Death Receptor 6. FASEB Journal 18(4-5): Abstract 770
Brown, H. 2004: Clive Mccay and the History of Nutrition. FASEB Journal 18(4-5): Abstract 708
Grudeva, J.; Nenova, I.; Karnolski, I.; Mateva, N. 2002: CLL - Significance of Some Prognostic Factors. Blood 100(11): Abstract No. 4954
Oppezzo, P.; Vuillier, F.; Vasconcelos, Y.; Magnac, C.; Dumas, G.; Payelle Brogard, B.; Pritsch, O.; Dighiero, G. 2002: CLL B-Cells Expressing AID Display a Dissociation between Class Switch Recombination and Somatic Hypermutation. Blood 100(11): Abstract No. 1468
Gabrilove, J.; Koenig, A. 1999: CLL The role of flavopiridol A CDK inhibitor. Cancer Investigation 17(Suppl 1): 1
Chung, D.H.; Humphrey, M.B.; Nakamura, M.C.; Seaman, W.E.; Daws, M.R. 2003: CLM-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. FASEB Journal 17(7): C317
McCormick, S.P.; Alexander, N.J.; Harris, L.J. 2010: CLM1 of Fusarium graminearum encodes a longiborneol synthase required for culmorin production. Applied and Environmental Microbiology 76(1): 136-141
Persaud Sawin, D.N.; Van Dongen, A.; Boustany, R.M. 2002: CLN3 modulates cell growth and apoptosis. American Journal of Human Genetics 71(4 Suppl): 321
Persaud Sawin, D.A.n N.; Boustany, R.M.ry N. 2003: CLN3p is localized to Golgi, early endosomes and plasma membrane. Pediatric Research 53(4 Part 2): 547A
Gao, H.; Espinola, J.; Macdonald, M.E. 2003: CLN6 encodes linclin, a novel 28kD transmembrane protein. American Journal of Human Genetics 73(5): 344
Handley, H.H.; Glassy, M.C.; Hagiwara, H.; Hagiwara, Y. 2000: CLNH11-specific antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1233(3)
Benedetti, F.; Serretti, A.; Colombo, C.; Barbini, B.; Lorenzi, C.; Campori, E.; Smeraldi, E. 2003: CLOCK gene and circadian mood fluctuations in bipolar depression. European Neuropsychopharmacology 13(Suppl 4): S223
Benedetti, F.; Serretti, A.; Cusin, C.; Mandelli, L.; Pirovano, A.; Zanardi, R.; Colombo, C.; Smeraldi, E. 2003: CLOCK gene influences insomnia during antidepressant treatment. European Neuropsychopharmacology 13(Suppl 4): S226
Basavaraju, K.P.; Cleary, P.; Ahluwalia, N.K. 2002: CLOTM testing Optimal number of biopsies required to diagnose Helicobacter pylori infection based on its topographical distribution. Gut 50(Suppl 2): A12
Vassallo, J.; Subramanian, V.; Ahluwalia, N.K. 1999: CLOTM vs histology Optimal numbers and site of gastric biopsies to diagnose Helicobacter Pylori. Gut 44(Suppl 1): A17
Varcamonti, M.; Naclerio, G.; Fusco, D.; De Felice, M. 2003: CLP/SSRA mediated stress adaptation in Streptococcus thermophilus. FEMS Congress of European Microbiologists Abstract Book 1: 317-318
Occhetta, E.; Bortnik, M.; Audoglio, R.; Vassanelli, C. 2003: CLS pacing in vasovagal syncope Final outcomes of the INASY Study. European Heart Journal 24(Abstract Suppl): 266
Yamada, M.K.; Uo, M.; Ohkawa, S.; Watari, F. 2003: CLSM and SEM quantitative analysis of surface topography of human teeth irradiated by NdYAG, ErYAG and CO2 lasers. Ishikawa, Isao , Reprint Author, Frame, John W, Aoki, Akira , Reprint Author Lasers in dentistry: Revolution of dental treatment in the new millennium: 135-137
Patel, A.S.; Perlman, E.J.; Coffin, C.M.; Griffin, C.A. 2000: CLTC-ALK fusion in inflammatory myofibroblastic tumor. American Journal of Human Genetics 67(4 Suppl 2): 73
Nag, B.; Bright, J.; Medicherla, S.; Du, C.; Dey, D.; Sriram, S. 1999: CLX-0300 A novel tyrphostin molecule that blocks proinflammatory cytokines in activated macrophages. FASEB Journal 13(7): A1503
Nag, B.; Neogi, P.; Dey, D.; Medicherla, S. 1999: CLX-0301 A new tyrphostin molecule for the treatment of diabetes. Diabetes 48(Suppl 1): A112-A113
Medicherla, S.; Dey, D.; Neogi, P.; Nag, B. 1999: CLX-0900 markedly increases glucose and cholesterol homeostasis in animal models of diabetes. Diabetes 48(Suppl 1): A118-A119
Dey, D.; Medicherla, S.; Neogi, P.; Nag, B. 1999: CLX-0901 A new class of orally active insulin sensitizer. Diabetes 48(Suppl 1): A119
Bao, J.; Sen, A.; Lapresca, P.; Zeynalzadegan, A.; Lee, H.; Li, T.K.; Jejurkar, P.; Rydzewski, J.; Gross, C.; Chen, L.; Neogi, P.; Pickford, L. 2003: CLX-090502, a novel small molecule anti-inflammatory compound is orally active in collagen-induced arthritis in mice. FASEB Journal 17(7): C133
Lane, N.; Yao, W.; Burghardt, A.; Majumdar, S.; Sen, A.; Gross, C. 2002: CLX-0921, a novel thiazolidinedione prevents loss of cancellous bone in adjuvant induced arthritis rats. Journal of Bone and Mineral Research 17(Suppl 1): S489
Hosking, B.; Schmid, H. 2004: CLiK as a treatment for preventing fly strike on lambs after mulesing. New Zealand Journal of Zoology 31(1): 92-93
Lee, Y.S.; Kim, D.J.; Lee, K.M.; Lim, Y.J.; Kim, Y.I.; Kang, J.S.; Ham, E.S.; Yun, S.Y.; Kim, Y.S.; Yang, Y.H.; Cho, D.H.; Hwang, Y.I.; Chang, K.Y.; Kim, Y.B.; Lee, W.J. 2002: CM1 induces apoptosis via two independent pathway in Burkitt lymphoma cells. FASEB Journal 16(4): A709
Kim, D.J.; Kim, S.H.; Hur, D.Y.; Kim, Y.I.; Kang, J.S.; Ham, E.S.; Yun, S.Y.; Cho, D.H.; Kang, C.J.; Lee, K.M.; Chang, K.Y.; Lee, W.B.; Kim, Y.B.; Lee, W.J. 2001: CM1 induces non-Fas mediated apoptosis in Burkitts lymphoma cell lines. FASEB Journal 15(5): A1033
Nanney, L.B.; Wamil, B.D.; Whitsitt, J.; Cardwell, N.L.; Davidson, J.M.; Hellerqvist, C.G. 2000: CM101 accelerates resurfacing by decreasing formation of pathogenic capillaries and blood flow during cutaneous wound repair. Wound Repair and Regeneration 8(4): 339
Yakes, F.M.; Wamil, B.D.; Sun, F.; Page, D.L.; Hellerqvist, C.G. 1999: CM101 up-regulates p53 specific DNA binding activity in an in vivo murine melanoma model. Proceedings of the American Association for Cancer Research Annual Meeting 40: 222
Larson, R.A. 2001: CMA-676 Mechanism of action and clinical results. Annals of Hematology 80(Suppl 2): S5
Dijoseph, J.; Armellino, D.; Khandke, K.; Boghaert, E.; Dougher, M.; Sridharan, L.; Kunz, A.; Moran, J.; Hamann, P.; Frost, P.; Damle, N. 2002: CMC-544, an Anti-CD22 Antibody-Targeted Calicheamicin Therapeutic for the Treatment of B Lymphoid Malignancies. Blood 100(11): Abstract No. 599
O'higgins, Niall 2001: CME accreditation in Europe Where are we now?. European Journal of Cancer 37(Suppl 6): S368
Vodusek, D.B. 2003: CME in the European Journal of Neurology. European Journal of Neurology 10(6): 607
Tralongo, P.; Di Mari, A.; Moruzzi, G.; Conti, G.; Aiello, R.; Risicato, R.; Ferrau, F.; Scifo, G.; Failla, G. 2001: CMF hepatic toxicity can be reduced by SAMe administration. European Journal of Cancer 37(Suppl 6): S357
Hutchins, L.; Green, S.; Ravdin, P.; Lew, D.; Martino, S.; Abeloff, M.; Lyss, A.; Henderson, C.; Allred, C.; Dakhil, S.; Pierce, I.; Goodwin, W.; Caton, J.; Rivkin, S.; Chapman, R.; Osborne, K. 1999: CMF versus CAF +- tamoxifen in high-risk node-negative breast cancer patients and a natural history follow-up study in low-risk node-negative patients Update of tamoxifen results. Breast Cancer Research and Treatment 57(1): 25
Boccardo, F.; Rubagotti, A.; Amoroso, D.; Mesiti, M.; Romeo, D.; Aldrighetti, D.; Genta, F.; Sismondi, P.; Irtelli, L.; Donati, D.; Farris, A.; Schieppati, G. 2001: CMF vs tamoxifen plus ovarian suppression as adjuvant treatment of ER-positive pre/perimenopausal breast cancer patients. Breast 10(Suppl 1): S32
Scott, C.N.; Yeh, C.G.; Fowlie, A.J.; Bachman, W.J.; Miro, A.M.; Hendy, C. 1999: CMI-977, a new 5-lipoxygenase inhibitor, demonstrates a longer duration of action than zileution in inhibiting calcium ionophore stimulated release of leukotriene B4 from human peripheral whole blood. Journal of Allergy and Clinical Immunology 103(1 Part 2): S134-S135
Thorpe, S.R.; Baynes, J.W. 2002: CML A brief history. Horiuchi, Seikoh , Reprint Author, Taniguchi, Naoyuki, Hayase, Fumitaka, Kurata, Tadao, Osawa, Toshihiko The Maillard reaction in food chemistry and medical science: Update for the postgenomic era: 91-99
Rizzoli, V.; Regazzi, E.; Mangoni, L.; Carlo Stella, C.; Cilloni, D.; Levinsky, A. 2000: CML Effects of tyrosine kinase inhibitor AG957 and anti Fas receptor antibody and induction of apoptosis by arachidonic acid on selected CD 34. Acta Haematologica (Basel) 103(Suppl 1): 55
Sun, T.; Giuseppe, M.; Lin, H.; Xie, S.; Stephens, C.L.; Belmont, J.W.; Arlinghaus, R.B. 2002: CML NOD/scid Mice as a Model To Investigate the Relationship between the Signal Transduction Pathways Affected by BCR/ABL and Their Biological Role Increased Survival Induced by a Mutant SH2-Bbeta, a Modulator of Jak2 Kinase. Blood 100(11): Abstract No. 2292
Giannini, B.; Martinelli, G.; Rosti, G.; Amabile, M.; Trabacchi, E.; Testoni, N.; Buonamici, S.; Ottaviani, E.; Soverini, S.; Bassi, S.; Pane, F.; Izzo, B 2002: CML Patients with Complete Karyotypic Response to STI-571 Therapy Shows Rapid Reduction of bcr-abl Transcripts. Blood 100(11): Abstract No. 3105
Amabile, M.; Martinelli, G.; Trabacchi, E.; Giannini, B.; Testoni, N.; Terragna, C.; Buonamici, S.; Ottaviani, E.; Soverini, S.; Bassi, S.; Vivo, A.D.; Tura, 2002: CML Patients with Resistance to STI-571 Therapy Could Be Monitored by Real-Time Quantification of BCR-ABL Transcripts. Blood 100(11): Abstract No. 4827
Rybak, M.E.; Rose, E.H. 2002: CML Therapy. Official Gazette of the United States Patent and Trademark Office Patents 1256(4)
Bolaños-Meade, J.; Sarkodee-Adoo, C.; Khanwani, S.L. 2002: CML after treatment for lymphoid malignancy: Therapy-related CML or coincidence?. American Journal of Hematology 71(2): 139
Rubio, A.; Recasens, V.; Odero, D.; Mayayo, P.; Rubio Felix, D.; Calasanz, M.J.; Giralt, M.; Giraldo, P. 2003: CML and Imatinib mesylate QOL and response related to karyotype. Blood 102(11): 322b
Ruester, M.; Franke, S.; Stein, G. 2003: CML and pentosidine in serum an urine of patients with chronic allograft nephropathy/benign nephrosclerosis and IgA-nephropathy. Journal of the American Society of Nephrology 14(Abstracts Issue): 780A
Alcorn, M.J.; Richmond, L.J.; Pearson, C.; Thomas, T.; Eaves, C.J.; Eaves, A.C.; Holyoake, T.L. 2001: CML leukapheresis products can be enriched for CD34+ cells and simultaneously depleted of CD15+ cells using a simple antibody cocktail. British Journal of Haematology 113(Suppl 1): 46
Lange, Thoralf; Krahl, Rainer; Al Ali, Haifa; Otto, Sandra; Musiol, Scarlet; Niederwieser, Dietger; Deininger, Michael W. 2003: CML patients in imatinib-induced molecular remission harbor higher levels of residual disease than patients after allografting. Blood 102(11): 416a
Gordon, M.Y.; Marley, S.B.; Davidson, R.J.; Nguyen, D.X.; Lewis, J.L.; Goldman, J.M. 2000: CML patients with advanced phase disease retain clonogenic progenitor cells which are responsive to interferon alfa and STI571 in vitro. Experimental Hematology 28(7 Suppl 1): 32-33
Pinilla-Ibarz, J.; Cathcart, K.; Scheinberg, D.A. 2000: CML vaccines as a paradigm of the specific immunotherapy of cancer. Blood Reviews 14(2): 111-120
Claviez, A.; Viehmann, S.; Harder, L.; Schoch, R.; Suttorp, M. 2000: CML with exclusive p190 expression and initial presentation as acute lymphoblastic leukemia in an adolescent boy. Onkologie 23(Sonderheft 7): 136
Sun, Baodong; Jiang, Guanchao; Zaydan, Muhammad Ali; La Russa, Vincent; Safah, Hana; Ehrlich, Melanie 2001: CML-specific hypermethylation of the ABL PA promoter in CML bone marrow cells quantitated by two PCR-based methods. Proceedings of the American Association for Cancer Research Annual Meeting 42: 479
Wu, C.J.; Chen, L.; Kutok, J.L.; Canning, C.M.; Alyea, E.P.; Yang, X.F.; Soiffer, R.J.; Ritz, J. 2002: CML28 and CML66 Are GVL-Associated Antigens That Are Highly Expressed in Proliferating Cells. Blood 100(11): Abstract No. 2285
Germing, U.; Gattermann, N.; Aul, C. 2003: CMML in adults A cryptic disease. Leukemia Research 27(Suppl 1): S15
Yuan, R.; Hartmond, U.; Kender, W.J. 2000: CMN-Pyrazole-induced abscission of mature Valencia oranges in relation to young fruit, root, and shoot growth. HortScience 35(3): 487
Lehmann, M.M.; Baumann, W.H.; Bitzenhofer, M.; Brischwein, M.H.; Ehret, R.; Schwinde, A.M.; Wolf, B. 1999: CMOS-based cellular biosensor in process and application. European Journal of Cell Biology 78(Suppl 49): 82
Gerardy Schahn, R.; Tiralongo, J.; Krapp, S.; Weinhold, B.; Ritz, V.; Jacob, U.; Munster, A.K. 2003: CMP-Neu5Ac-synthesis why in the cell nucleus?. FASEB Journal 17(4-5): Abstract 235
Suzuki, A. 2002: CMP-NeuAc hydroxylase. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 352-356
Waldman, B.C.; Sanders, R.F. 2000: CMP-sialic acid transport across the Golgi membrane Electroneutral exchange for dianionic pyrimidine nucleoside monophosphates. Glycobiology 10(10): 1104
Gerardy Schahn, Rita 2002: CMP-sialic acid transporter. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 524-530
Clark, G.J.; Fitzpatrick, S.; Kuo, B.; Modra, C.; Jamriska, L.; Hart, D.N.J. 2002: CMRF-35A, CMRF-35H: potential new CD. Journal of Biological Regulators and Homeostatic Agents 16(3): 233-235
Zhao, T.; Milik, E.; Smith, C.M.; Wild, L. 2001: CMSMBR Web portal to data analysis tools and databases. Plant Biology (Rockville) : 166-167
Oh, J.H.; Kim, J.C.; Cho, H.K. 2001: CMT inhibits the progression of inflammation in endotoxin induced uveitis. IOVS Investigative Ophthalmology and Visual Science 42(4): S918
Selzer, M.G.; Zhu, B.; Block, N.L.; Lokeshwar, B.L. 1999: CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer. Annals of the new York Academy of Sciences 878: 678-682
Llavaneras, A.; Golub, L.M.; Rifkin, B.R.; Heikkilä, P.; Sorsa, T.; Teronen, O.; Salo, T.; Liu, Y.; Ryan, M.E.; Ramamurthy, N.S. 1999: CMT-8/clodronate combination therapy synergistically inhibits alveolar bone loss in LPS-induced periodontitis. Annals of the new York Academy of Sciences 878: 671-674
Shy, M.E.; Krajewski, K.; Turansky, C.; Garbern, J.; Kamholz, J.A.; Lewis, R. 1999: CMT1A phenotype correlates with secondary axonal degeneration but not demyelination. Neurology 52(6 Suppl 2): A217
Bernard, R.B.; Navarro, A.; Pouget, J.; Desnuelle, C.; Philip, N.; Fontes, M.; Levy, N. 1999: CMT1A-REPs based PCR strategies to identify duplications/deletions in Charcot-Marie-Tooth type 1A and Hereditary Neuropathies with liability to Pressure Palsies. American Journal of Human Genetics 65(4): A284
Schulenburg, A.; Watkins Riedel, T.; Kalhs, P.; Knoebl, P.; Keil, F.; Rabitsch, W.; Mitterbauer, M.; Loidolt, H.; Greinix, H.T. 2000: CMV - monitoring after peripheral blood stem cell transplantation by pp65 antigen and quantitative PCR. Onkologie 23(Sonderheft 7): 18
Tegtmeier, G.E.; Henderson, S.E.; Blosser, J.K.; Drew, W.L.; Miner, R.; Busch, M.P. 1999: CMV DNA in plasma of seroconverting and anti-CMV seroprevalent blood donors. Transfusion 39(10 Suppl): 116S
Bonon, Sandra H.A.; Rossi, Claudio L.; De Souza, Carmino A.; Vigorito, Afonso C.; Costa, Sandra C.B. 2002: CMV Infection Surveillance with Nested-PCR and Antigenemia Assays in Patients Who Received or Not Ganciclovir Universal Prophylaxis in HLA Identical Sibling Hematopoietic Stem Cell Transplants. Blood 100(11): Abstract No. 3336
Kreuzwieser, E.; Kletzmayr, J.; Watkins Riedel, T.; Kovarik, J.; Klauser, R. 2000: CMV PCR in prediction of failure of ganciclovir prophylaxis in renal transplant recipients. Nephrology Dialysis Transplantation 15(9): A265
Djurkovic, S.; Papadopoulos, E.; Jaffe, D.; Monroe, A.; Papanicolaou, G. 2002: CMV Reactivation Following T-Cell Depleted Allogeneic Hematopoetic Stem Cell Transplantation Incidence, Patterns, Risk Factors and Outcome in Related and Unrelated HSCT. Blood 100(11): Abstract No. 5360
Krogerus, L.; Soots, A.; Loginov, R.; Bruggeman, C.; Ahonen, J.; Lautenschlager, I. 2001: CMV accelerates tubular apoptosis in a model of chronic renal allograft rejection. Transplantation Proceedings 33(1-2): 254
So, S. 2001: CMV and EBV-PTLD after liver transplantation. Transplantation Proceedings 33(1-2): 1317-1319
Stassen, F.R.M.; Vliegen, I.; Bruggeman, C.A. 2003: CMV and atherosclerosis. Proesch, Susanna , Reprint Author, Cinatl, Jindrich, Scholz, Martin New aspects of CMV-related immunopathology: 23-32
Roback, J.D. 2002: CMV and blood transfusions. Reviews in Medical Virology 12(4): 211-219
Adragao, T.; Jorge, C.; Pita Negrao, A.; Acosta, J.; Macedo, A.; Paixao, P.; Correia, E.Jr 1999: CMV antigenemia and CD57 T-cell subsets after renal transplantation. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 718A
Voilokova, R.Y.; Moisuk, Y.G.; Balakirev, E.M.; Khorobrykh, V.V.; Tiunina, G.K. 1999: CMV antigenemia in donors as a risk factor for renal transplant recipients. Nephrology Dialysis Transplantation 14(9): A282
Mayorga, H.; Gonzalez Michaca, L.; Vanegas, R.; Sierra Madero, J.; Munoz, T.; Morales, L.; Alberu, J.; Correa Rotter, R. 2003: CMV antigenemia is not associated with adverse graft outcome or CMV disease in intermediate risk transplant recipients. Journal of the American Society of Nephrology 14(Abstracts Issue): 188A-189A
Tin, H.H.ng Jack; Huh, C.; Scileppi, T.A.; Iswara, K.; Tenner, S. 2003: CMV colitis as a complication of gastric bypass surgery. American Journal of Gastroenterology 98(9 Suppl): S169
Mitchell, S.M.; Zambarakji, H.J.; Newson, R.B.; Nelson, M.R. 1999: CMV diagnoses and progression of CD4 counts and HIV viral load measurements in HIV patients on HAART. IOVS Investigative Ophthalmology and Visual Science 40(4): S188
Salmon, D. 1999: CMV disease in AIDS. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 34
Hilinski, J.; Gaye Robinson, L.; Graham, F.R.; Shaw, M.; Nesheim, S.; Hymes, L. 1999: CMV disease in pediatric renal transplant recipients receiving Mycophenolate Mofetil. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 758A
Liberek, A.; Szlagatys Sidorkiewicz, A.; Rytlewska, M.; Bako, W.; Sikorska Wisniewska, G.; Gora Gebka, M.; Luczak, G.; Korzon, M. 2003: CMV hepatitis in newborns and infants Clinical picture and diagnostic problems. Journal of Hepatology 38(Suppl 2): 152
Staskewitz, A.; Kirste, G.; Toenshoff, B.; Weber, L.T.; Brandis, M.; Zimmerhackl, L.B. 1999: CMV high risk status is associated with increase of CMV-infection, but not acute rejection after pediatric renal transplantation using MMF. Kidney and Blood Pressure Research 22(4-6): 359
Cailhier, J.F.; Boucher, A.; Béliveau, C.; Poirier, L.; Delorme, J.; Weiss, K.; Laverdière, M.; Hébert, M.J.; Pichette, V.; Dandavino, R. 2001: CMV in kidney transplants in the tacrolimus-mycophenolate era. Transplantation Proceedings 33(1-2): 1196-1197
Krogerus, L.; Soots, A.; Bruggeman, C.; Loginov, R.; Ahonen, J.; Lautenschlager, I. 2003: CMV increases TNF-alpha expression in a rat kidney model of chronic rejection. Transplantation Proceedings 35(2): 803
Inkinen, K.; Soots, A.; Krogerus, L.; Bruggeman, C.; Ahonen, J.; Lautenschlager, I. 1999: CMV increases collagen synthesis in chronic rejection in rat renal allograft. Transplantation Proceedings 31(1-2): 1361
Devito Haynes, L.D.; Waldman, W.J.; Bushkin, Y.; Love, R.B.; Burlingham, W.J. 2002: CMV infected endothelial cells stimulate blood mononuclear cells to release beta2 microglobulin-free HLA. Journal of Heart and Lung Transplantation 21(1): 135-136
Kambham, N.; Vij, R.; Cartwright, C.; Longacre, T. 2003: CMV infection A significant cause of steroid-refractory ulcerative colitis. Modern Pathology 16(1): 123A
Giovanelli, S.; D'errico, A.; Grazi, G.L.; Lodato, F.; Colecchia, A.; Tame, M.R.; Azzaroli, F.; Vetrone, G.; Del Gaudio, M.; Roda, E.; Mazzella, G. 2004: CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis. Journal of Hepatology 40(Suppl 1): 45-46
Davrinche, C. 2004: CMV infection and cross presentation a link between innate and adaptive antiviral response. Virologie 8(1): 13-21
Sanz, J.; Sanz, G.; Jimenez, C.; Acosta, B.; Martin, G.; Lorenzo, I.; Moscardo, F.; Lorente, P.; Linares, M.D.; Cantero, S.; Martinez, J.; Jarque, I. 2003: CMV infection and disease in adult patients undergoing unrelated donor cord blood transplantation. Blood 102(11): 476b
Gerstenkorn, C.; Robertson, H.; Bell, A.; Shenton, B.; Talbot, D. 2001: CMV infection as a contributory factor for renal allograft injury and loss. Transplantation Proceedings 33(4): 2461-2462
Pomara, G.; Barzon, L.; Manassero, F.; Rappa, F.; Cappello, F.; Palu, G.; Selli, C. 2004: CMV infection of a non-functioning adrenal adenoma Innocent bystander or pathogenetic agent?. European Urology Suppls 3(2): 8
Glanville, A.R.; Valentine, V.G.; Aboyoun, C.L.; Malouf, M.A. 2004: CMV mismatch is not a risk factor for survival or severe bronchioitis obliterans syndrome after lung transplantation. Journal of Heart and Lung Transplantation 23(2S): S43
Warraich, I.; Ludmann, S.A.; Zhang, H.; Aja, T.; Gladstone, P.; Ching, B.; Bauer, K.D.; Harrington, D.S.; Terrand, J.J. 2001: CMV pp65 antigenicity enhancement by anti-apoptotic agent IDN7312 with Automated Cellular Imaging analysis. Laboratory Investigation 81(1): 237A
Steddon, S.J.; Ball, E.A.; Aitken, C.; Rudge, C.J.; Raftery, M.J.; Yaqoob, M.M. 1999: CMV prophylaxis Infection or disease as the target?. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 766A
Peccatori, J.; Assanelli, A.; Dodero, A.; Lillo, F.; Pescarollo, A.; Servida, P.; Corti, C.; Camba, L.; Ciceri, F.; Bordignon, C.; Corradini, P.; Bregni, M. 2001: CMV reactivation in patients undergoing reduced-intensity allogeneic stem cell transplantation Association with graft-versus-host disease and transplant related mortality. Blood 98(11 Part 1): 395a-396a
Shimakawa, M.; Kono, C.; Nagai, T.; Hori, S.; Tanabe, K.; Toma, H. 2002: CMV retinitis after renal transplantation. Transplantation Proceedings 34(5): 1790-1792
L.P.ra, G.; Bottone, L.; Ivaldi, F.; Pelizzoli, R.; Lanino, E.; Manca, F. 2003: CMV specific CD4 T cell lines for immunoreconstitution Stimulation with immunodominant peptides and use of sealed culture systems. Blood 102(11): 717a
Arroz, M.J.; Gaiao, G.; Pinto, L.; Freire, M.; Ordway, D.; Ventura, F. 2000: CMV specific intracellular cytokine expression in healthy controls. Cytometry 42(5): 325-326
Meric, C.; Cadoz, M. 2003: CMV vaccines to prevent congenital infection An overview of preclinical and clinical results. Proesch, Susanna , Reprint Author, Cinatl, Jindrich, Scholz, Martin New aspects of CMV-related immunopathology: 195-206
Karpinski, M.; Rush, D.; Jeffery, J.; Pochinco, D.; Nickerson, P. 2001: CMV viremia is a significant confounder for CD69 expression as a peripheral blood lymphocyte biomarker of rejection. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 860A
Franke, D.; Courault, K.; Radtke, M. 2000: CMV-IgG-ELISA PKS medac A new quantitative assay for the detection of anti-HCMV IgG antibodies. Infection 28(Suppl 1): 6
Meijer, E.; Dekker, A.W.; Verdonck, L.F. 2002: CMV-Seropositivity No Longer Affects Outcome in Recipients of T Cell Depleted Grafts from Matched Unrelated Donors. Blood 100(11): Abstract No. 3332
Lacey, S.F.; Gallez Hawkins, G.; Fenge, R.; Sanborn, M.; Sano, A.; Patane, K.; Lomeli, N.; Longmate, J.; Martinez, J.; Spielberger, R.; Diamond, D.J.; Forman, S.J.; Zaia, J.A. 2002: CMV-Specific Tetramer Assay Is Not a Marker for Protection from CMV Viremia. Blood 100(11): Abstract No. 3328
Pirskanen, R.; Nennesmo, I.; Grutzmeier, S. 2000: CMV-encephalitis in HIV-positive gay patients. Journal of Neurovirology 6(3): 260
Edreva, A.; Kostova, D.; Gesheva, E. 2001: CMV-pathogenesis in tolerant and susceptible cucumber plants I Biochemical approach. Dokladi na B"lgarskata Akademiya na Naukite 54(8): 67-72
Sester, M.; Sester, U.; Gaertner, B.; Heine, G.; Girndt, M.; Mueller Lantzsch, N.; Meyerhans, A.; Koehler, H. 2000: CMV-specific CD8 T-cells dominate during primary CMV-infection in humans. Kidney and Blood Pressure Research 23(3-5): 336
Gamadia, L.E.; Rentenaar, R.J.; Remmerswaal, E.B.; Surachno, S.; Weel, J.F.; Toebes, M.; Schumacher, T.N.; van Lier, R.A.; ten Berge, I.J. 2001: CMV-specific CD8(pos) T lymphocyte differentiation in latent CMV infection. Transplantation Proceedings 33(1-2): 1802-1803
Chuang, E.L.; Riddell, S.R.; Fuller, F.; Stevens Ayers, T.; Corey, L.; Boeckh, M. 1999: CMV-specific T lymphocyte precursor frequencies and CMV viral load in patients with AIDS and CMV retinitis who respond to HAART. IOVS Investigative Ophthalmology and Visual Science 40(4): S189
Sester, M.; Sester, U.; Gaertner, B.; Heine, G.; Girndt, M.; Mueller Lantzsch, N.; Meyerhans, A.; Koehler, H. 2000: CMV-specific cellular immune responses differ during distinct phases after kidney transplantation and can serve as parameter to predict CMV complications. Infection 28(Suppl 1): 27
De Bolle, L.; Andrei, G.; Snoeck, R.; Van Lommel, A.; Otto, M.; Bousseau, A.; Roy, C.; De Clercq, E.; Naesens, L. 2003: CMV423, a potent and selective inhibitor of human herpesvirus 6 exerts its antiviral action through inhibition of cellular protein tyrosine kinase activity. Antiviral Research 57(3): A59
Valantine, H.A.; Luikart, H.; Doyle, R.L.; Theodore, J.; Hunt, S.A.; Robbins, R.C.; Reitz, B.A. 1999: CMVIG favorably affects long-term outcome after heart, heart-lung and lung transplantation. Journal of Heart and Lung Transplantation 18(1): 81
Yassi, M.N.; Roossinck, M.J. 2002: CMVdelta2b can interfere with the accumulation of wild type CMV in zucchini squash plants in a cross-protection like phenomenon that involves RNA silencing. Phytopathology 92(6 Suppl): S89
He, T.C.; Vogelstein, B.; Kinzler, K.W. 2000: CMYC is regulated by Tcf-4. Official Gazette of the United States Patent and Trademark Office Patents 1239(5)
Lough, J.W.; Balza, R.; Isaac, A.; Mcallister, D.; Mcdonald, C.; Ohiaeri, A.; Stefaniak, H.; Tang, X. 2001: CMYST An embryonic heart-specific transcriptional co-activator?. FASEB Journal 15(4): A377
Ohashi, K.; Meuse, L.; Schwall, R.; Kay, M.A. 2001: CMet activation allows persistent engraftment of ectopically transplanted xenogenic human hepatocytes in mice. Transplantation Proceedings 33(1-2): 587-588
Jordheim, L.P.; Lavenir, R.; Paret, A.; Nicolini, F.; Thomas, X.; Cros, E.; Dumontet, C.M.; Galmarini, C.M. 2003: CN-II nucleotidase protein in blast cells is a prognostic factor in acute myeloid leukemia. Blood 102(11): 254b
Shimizu, K.; Chen, W.; Liang, Y.; Isoda, R.; Deng, W.; Li, Y. 2001: CNBP enhances bone formation by promoting osteoblast cell proliferation and inhibiting osteocalcin expression. Journal of Bone and Mineral Research 16(Suppl 1): S205
Anjaneyulu,K.; Raghupathi,H.B. 2010: CND and PCA approaches for multivariate diagnosis of nutrient imbalance in papaya. Acta Horticulturae 851: 363-368
Kato, Y.; Murakami, S.; Nakano, T.; Sato, F. 2001: CND41, a chloroplast DNA-binding protease, is involved in Rubisco degradation. Photosynthesis Research 69(1-3): 175
Wissinger, B.; Gamer, D.; Jaegle, H.; Mayer, S.; Andreasson, S.; Rosenberg, T.; Jurklies, B.; Sener, E.C.; Tatlipinar, S.; Akarsu, N.; Hanna, D.B.; Jacobson, S.G.; Rudolph, G.; Kellner, U.; Apfelstedt Sylla, E.; Sharpe, L.T.; Kohl, S. 1999: CNGA3 mutations in cone photoreceptor disorders. American Journal of Human Genetics 65(4): A498
Kobashigawa, J.A. 2004: CNIs in heart transplantation Minimizing the cardiovascular risk - Guest editors introduction. Journal of Heart and Lung Transplantation 23(5)
Hebert, T. 2001: CNMPs, TMDLs, CAFOs/AFOs, effluent guidelines, and other issues. Journal of Dairy Science 84(Suppl 1): 141
Rubio Borja, M.E.ena E.; Tripp, F.J.; Baez, E.; Rivas, S.; Rubio, B.; Baltasar, S. 2002: CNOP vs CNOP-R vs Rituximab Monotherapy as First - Line Therapy for Indolent Non-Hodgkin Lymphoma A Preliminary Report from the Mexican Multicentric Hematology Study Group. Blood 100(11): Abstract No. 4794
Callahan, W.; Powell, M.D.; Toop, T. 2003: CNP is more potent than ANP as a stimulant of particulate guanylyl cyclase in the teleost gill. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 134A(Suppl 1): S48
Thiriet, P.; Jouvert, N.; Gobaille, S.; Gough, B.; Ali, S.F.; Zwiller, J. 2001: CNP peptide modulates the cocaine-induced egr-1 gene expression through the activation of cGMP-dependent protein kinase in rat striatum. Journal of Neurochemistry 78(Suppl 1): 171
Chen,M.M.; Yin,H.B.; O'Connor,P.; Wang,Y.S.; Zhu,Y.G. 2010: CNP stoichiometry and specific growth rate of clover colonized by arbuscular mycorrhizal fungi. Plant And Soil 6: 1 2, 21-29
Sterner, R.W.; Schulz, K.L. 2001: CNP stoichiometry in Lake Superior. IAGLR Conference Program and Abstracts 44: 130
Schade, J.D.; Elser, J.J.; Fagan, W.F.; Hobbie, S.E. 2001: CNP stoichiometry of soil, plants, and invertebrates along a moisture gradient in the Sonoran Desert. Ecological Society of America Annual Meeting Abstracts 86: 198
Mutoh, T.; Yagi, T. 1999: CNR, cadherin-related neuronal molecule, family have a different localization mechanism to synaptic membrane against the other cadherins. Society for Neuroscience Abstracts 25(1-2): 997
Gonda, K.; Yoshida, A.; Oami, K.; Takahashi, M. 2003: CNRC Controlling factor of voltage-gated Ca2+ channels in paramecium. Genes and Genetic Systems 78(6): 498
Kiehl, R. 1999: CNS / psyche - blood / immune system / cells - acupuncture / drugs - electrophysiology and thermodynamics The redox potential / electron transfer is responsible for stress protein or O2-synthesis / transport and proliferation. European Journal of Cell Biology 78(Suppl 49): 89
Hampson, N.B. 2004: CNS O2 toxicity Dr Hampsons response. Undersea and Hyperbaric Medicine 31(2): 191
Bernardi, F.; Pluchino, N.; Stomati, M.; Pieri, M.; Genazzani, A.R. 2003: CNS: sex steroids and SERMs. Annals of the new York Academy of Sciences 997: 378-388
Smith, L.H.; Azzarelli, B. 2003: CNS angiitis as the presenting manifestation of probable graft-versus-host disease. Neurology 60(5 Suppl 1): A447
Kerza-Kwiatecki, A.P.; Amini, S. 1999: CNS as an HIV-1 reservoir; BBB and drug delivery. Journal of Neurovirology 5(2): 113-114
Lankford, K.L.; Imaizumi, T.; Fodor, W.; Kocsis, J.D. 1999: CNS axon regeneration and remyelination using xenogenic cell therapies. Society for Neuroscience Abstracts 25(1-2): 210
Cano, G.; Syed, A.F.; Rinaman, L.; Rabin, B.S.; Card, J.P. 1999: CNS circuitry involved in the control of splenic immune function. FASEB Journal 13(4 Part 1): A57
Gomes, H.R.; Livramento, J.A.; Machado, L.R.; Gherpelli, J.L.D.; Spina Franca, A. 2000: CNS cryptococcosis and tuberculosis in AIDS Predictive value patterns in CSF. Journal of Neurovirology 6(3): 270
Rahman, S.Z.; Khan, R.A.; Kumar, A. 2003: CNS depressant effect of Delphinium denudatum Wall with special reference to its role in morphine addiction. Journal of Neurochemistry 87(Suppl 1): 68
O'donnell, D.; Cao, J.; Ahmad, S.; Walker, P. 1999: CNS distribution of the novel rat thyrotropin-releasing hormone receptor subtype, TRHR2, differs markedly from that of TRHR1. Society for Neuroscience Abstracts 25(1-2): 2219
Riederer, P.; Battistin, L.; Youdim, M.B.H.; Leon, A.; Cagnin, A.; Gerstenbrand, F.; Grunblatt, E. 2003: CNS drug action on gene expression. European Journal of Neurology 10(Suppl 1): 219
Penn, R.D.; Kroin, J.S. 2000: CNS drug delivery movement disorders. Lozano, Andres M Author Progress in Neurological Surgery; Movement disorder surgery 371-380
Scriabine, A. 2003: CNS drugs at the Experimental Biology, 2003 Meeting, San Diego, CA, April 11-15, 2003. Cns Drug Reviews 9(3): 313-318
Iregren, A. 2000: CNS effects from occupational aluminum exposure. Neurotoxicology (Little Rock) 21(5): 871-872
Levander, S. 2000: CNS effects in the correct perspective. Allergy 55(Suppl 60): 35-39
Hindmarch, I. 2002: CNS effects of antihistamines Is there a third generation of non-sedative drugs?. Clinical and Experimental Allergy Reviews 2(1): 26-31
Davis, J.M.; Zhao, Z.W.; Hand, G.A.; Burghardt, P.; Stock, H.; Buggy, J. 2001: CNS effects of caffeine and adenosine on fatigue in rats during treadmill exercise. Medicine and Science in Sports and Exercise 33(5 Suppl): S43
Heesch, C.M.; Foley, C.M. 2001: CNS effects of ovarian hormones and metabolites on neural control of circulation. Annals of the new York Academy of Sciences 940: 348-360
Hesseling, M.; Broome, J.C.; Mallucci, C.; McDowell, H. 2002: CNS embryonal sarcoma. Medical and Pediatric Oncology 38(3): 214
Ames, A. 2000: CNS energy metabolism as related to function. Brain Research. Brain Research Reviews 34(1-2): 42-68
Thomas, S.A.; Prince, W.; Bye, A.; Segal, M.B. 1999: CNS entry of a new anti-HIV non-nucleoside reverse transcriptase inhibitor, GW420867X. Society for Neuroscience Abstracts 25(1-2): 1761
Lukic, M.L.; Saleh, A.M.; Mensah Brown, E.; Camasamudram, V.; Shahin, A. 2003: CNS expression of pro-apoptotic and anti-apoptotic molecules after EAE inducton in susceptible and resistant strain of rats. FASEB Journal 17(7): C260
Kadoshima, T.; Kawasaki, T.; Glover, J.C.; Hirata, T.; Fujisawa, H. 1999: CNS fiber projection in Neuropilin-1 mutant embryos. Society for Neuroscience Abstracts 25(1-2): 242
Yanai, K.; Mobarakeh, J.I.; Watanabe, T. 2002: CNS functions of histamine receptors demonstrated by studies of the receptor gene knockout mice. Japanese Journal of Pharmacology 88(Suppl 1): 35P
Wang, S.; Li, Y. 2003: CNS gene transfer facilitated by a novel controlled release system based on DNA complexes of degradable polycation PPE-EA. Journal of Neurochemistry 87(Suppl 1): 87
Ratner, N.; Miller, S.J.; Ling, B.; Huang, Y.N.; Bennett, M.R.; Mckinnon, R.; Rizvi, T.A. 2002: CNS glial progenitors and Schwann cells in neurofibromatosis type 1. Journal of Neurochemistry 81(Suppl 1): 2
Bruha, R.; Marecek, Z.; Martasek, P.; Nevsimalova, S.; Petrtyl, J.; Urbanek, P. 2004: CNS impairment in the children from patients with Wilson disease. Journal of Hepatology 40(Suppl 1): 164
Perry, V.Hugh 2000: CNS inflammation and its role in HIV dementia. Journal of Neurovirology 6(3): 240
Goralski, K.B.; Renton, K.W. 2002: CNS inflammation depresses P-glycoprotein mediated digoxin removal from the CNS and its elimination in the bile. FASEB Journal 16(5): A940
Ure, D.; Rodriguez, M. 1999: CNS inflammatory, demyelination of the mouse spinal cord results in secondary injury to descending neurons. Society for Neuroscience Abstracts 25(1-2): 1567
Song, D.; Sharkey, K.A.; Lee, S.S. 1999: CNS influence on hyperdynamic circulation in portal hypertensive rats. Hepatology 30(4 Part 2): 313A
Furmanski, O.; Kumar, S.M.; Chen, A.; Einhorn, B.; Sahley, C.L.; Muller, K.J. 1999: CNS injury rapidly induces eNOS immunoreactivity coincident with DAF-2A staining in Hirudo medicinalis. Society for Neuroscience Abstracts 25(1-2): 1266
Hadziefendic, S.; Erokwu, B.O.; Haxhiu, M.A. 1999: CNS innervation of the posterior cricoarytenoid muscle A transneuronal labeling study using pseudorabies virus. FASEB Journal 13(4 Part 1): A492
Fischer-Smith, T.; Croul, S.; Sverstiuk, A.E.; Capini, C.; L'Heureux, D.; Régulier, E.G.; Richardson, M.W.; Amini, S.; Morgello, S.; Khalili, K.; Rappaport, J. 2001: CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. Journal of Neurovirology 7(6): 528-541
Pachner, A.R.; Schaefer, H.; Zhang, W.F.n 1999: CNS invasion in a rhesus model of lyme neuroborreliosis Association with delayed isotype switching of anti-spirochetal antibody. Neurology 52(6 Suppl 2): A188
Lossos, A.; Lossos, I.S.; Bokstein, F.; Siegal, T. 1999: CNS involvement by systemic non-Hodgkins lymphomas Results of treatment with high dose methotrexate-based combination chemotherapy. Neurology 52(6 Suppl 2): A281
Modoni, A.; Silvestri, G.; Pomponi, M.G.; Mangiola, F.; Tonali, P.A.; Marra, C. 2003: CNS involvement in DM1 Definition of the pattern of cognitive impairment and analysis of genotype-phenotype correlations. Annals of Neurology 54(Suppl 7): S74
Vedolin, L.; Jardim, L.; Schwartz, I.V.D.; Cecchin, C.; Ashton Prolla, P.; Aesse, F.; Pitta Pinheiro, C.; Marconato, J.; Giugliani, R. 2003: CNS involvement in Fabry disease A magnetic resonance imaging, magnetic resonance angiography and magnetic resonance spectroscopy study. Acta Paediatrica 92(Suppl 443): 113
Andersson, K.-E.; Pehrson, R. 2003: CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. Drugs 63(23): 2595-2611
Rodriguez Munoz, M.; Lopez Fando, A.; Sanchez Blazquez, P.; Garzon, J. 2002: CNS levels of G-protein regulator phosducin-like protein in mice rendered tolerant to morphine. Methods and Findings in Experimental and Clinical Pharmacology 24(Suppl A): 152
Erdman, W.A.; Skiest, D.; Chang, W.; Fleckenstein, J.; Mathews, D.; Oz, O.K.; Devous, M.D.; Bonte, F.J. 1999: CNS lymphoma vs toxoplasma Are subjective thallium SPECT interpretations worthwhile?. Journal of Nuclear Medicine 40(5 Suppl): 200P
Maschke, M.; Kastrup, O.; Diener, H.-C. 2002: CNS manifestations of cytomegalovirus infections: diagnosis and treatment. Cns Drugs 16(5): 303-315
Lopez, O.L.; Becker, J.T.; Cidis Meltzer, C.; Scanlon, J.; Greer, P.; Dekosky, S.T. 2003: CNS mechanisms of dementia treatment. Neurology 60(5 Suppl 1): A413
Green, S.D.; Groves, M.; Hsu, S.; Sahin, A. 2000: CNS metastases of breast carcinomas Analysis of clinicopathologic features and HER-2/neu overexpression. Laboratory Investigation 80(1): 22A
Carson, M.J. 2004: CNS microglia active regulators of immune responses. FASEB Journal 18(4-5): Abstract 63
Hurley, A.C.; Lindell, S.; Hommer, D.W.; Shoaf, S.E.; Higley, J.D. 1999: CNS monoamine metabolites and plasma hormones as predictors of alcohol consumption in rhesus macaques. American Journal of Primatology 49(1): 64
Gow, A.; Southwood, C.M.; Li, J.S.; Pariali, M.; Riordan, G.P.; Danias, J.; Bronstein, J.M.; Brodie, S.E.; Kachar, B.; Lazzarini, R.A. 2000: CNS myelin and Sertoli cell tight junction stands are absent in Osp/claudin 11-null mice. Journal of Neurochemistry 74(Suppl ): S35
Rout, U.; Bessert, D.A.; Carlock, L.; Ghandour, M.S.; Armant, R.; Skoff, R.P. 2000: CNS myelin protein genes are robustly expressed in many tissues including preimplantation embryos. Journal of Neurochemistry 74(Suppl ): S31
Elazar, M.; Zlotkin, E. 2001: CNS neurotoxicity mediated through recombinant baculovirus expressing an insect selective neurotoxicity. Toxicon 39(2-3): 142
Beyak, M.J.; Collman, P.I.; Xue, S.; Valdez, D.T.; Diamant, N.E. 2001: CNS nitric oxide is responsible for vagal-mediated basal tone and contraction in the cat LES. Gastroenterology 120(5 Suppl 1): A 712
Bitterman, N. 2004: CNS oxygen toxicity. Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 31(1): 63-72
Babich, J.W.; Smith, M.P.; Kozikowski, A.P.; Bonab, A.A.; Livni, E.; Fischman, A.J. 2001: CNS pharmacodynamics of a novel cocaine medication Pet studies with 11C cocaine. Journal of Nuclear Medicine 42(5 Suppl): 15P-16P
Yeung, S.C.S.A.; Rurak, D.; Gruber, N.; Riggs, K.W.yne 2003: CNS pharmacokinetics of diphenhydramine in sheep. Drug Metabolism Reviews 35(Suppl 2): 160
Shaoyong, Y.; Long, Jeff, M.; Nass, Petra, H.; Ingram, Donald, K.; Crowell, Michael, D. 2000: CNS processing of noxious colorectal distention A murine model using immediate early gene transcription of c-Fos. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A841
Berman, S.M.; Naliboff, B.D.; Fitzgerald, L.; Antolin, T.; Camplone, A.; Mayer, E.A. 2000: CNS reactivity in irritable bowel syndrome. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A444-AGA A445
Brocke, S.; Izikson, L.; Ratner, M.; Ben Chetrit, E.; Quigley, L.; Grabovsky, V.; Soffer, D.; Pikarsky, E.; Peled, A.; Taub, D.; Alon, R.; Biton, A. 2003: CNS recruitment of pathogenic T lymphocytes by CXCL12 and integrin expressed at the apical brain endothelium. Journal of Neurochemistry 85(Suppl 1): 96
Tahmoush, A.J.; Amir, M.S.; Quang, T.; Israel, H.L.; Patrick, H. 2000: CNS sarcoidosis CSF and MRI findings. Neurology 54(7 Supp 3): A447-A448
Konitsiotis, S.; Argyropoulou, M.I.; Kosta, P.; Giannopoulou, M.; Efremidis, S.C.; Kyritsis, A.P. 2002: CNS siderosis after brachial plexus avulsion. Neurology 58(3): 505
Dopico, A.M.; Widmer, H.; Wang, G.; Lemos, J.R.; Treistman, S.N. 1999: CNS somata and terminal BK isochannels differ in kinetics, role in spike repolarization, and sensitivity to Ca++, ethanol, and blockers. Biophysical Journal 76(1 Part 2): A329
Moss, T.H.; Shepherd, S.F.; Mccarthy, K.P.; Anthony, P.P. 2000: CNS toxicity of nimorazole used as a hypoxic cell sensitiser. Brain Pathology 10(4): 654
Strempel, J.M.; Webster, R.B.; Vercelli, D. 2002: CNS-1 is a regulator of human IL-13 transcription. FASEB Journal 16(4): A693
Forbes, I.T.; Jones, G.E. 1999: CNS-active pyridinylurea derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1219(1): 556
Stafford, G.I.; Van Staden, J.; Jager, A.K. 2003: CNS-affecting plants traditionally used in southern Africa. South African Journal of Botany 69(2): 243
Vyas, S.P. 2003: CNS-delivery via conjugation to biological carriers: physiological-based approaches. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 61: 189-219
Mccormick, J.A.; Lyons, V.; Seckl, J.R.; Chapman, K.E. 2000: CNS-derived cell-line specificity and autoregulation of the glucocorticoid receptor gene promoter region. European Journal of Neuroscience 12(Suppl 11): 309
Young, M. 2004: CNS-derived stem cell transplants to the retina. Graefe's Archive for Clinical and Experimental Ophthalmology 242(1): 64
Ivanova, M.M. 2001: CNS-lupus Problems and achievements. Terapevticheskii Arkhiv 73(5): 25-28
Considine, R.V. 2000: CNS-neuropeptide interactions and obesity. American Journal of Hypertension 13(4 Part 2): 314A-315A
Chen, W.K.; Wu, K.; Hartt, G.; Zhang, D.; Pierson, S.; Oberdick, J.; Boris Lawrie, K.; Young, A. 2002: CNS-specific and cAMP-inducible expression of fusion genes controlled by multiple human neuronal nitric oxide synthase promoters. FASEB Journal 16(5): A952
Prokai, L.; Prokai Tatrai, K.; Zharikova, A.D.; Wu, J.; Ouyang, X.; Wu, W.M.; Bodor, N.; Simpkins, J.W. 2000: CNS-targeting of centrally active TRH analogs using progenitor sequences. Abstracts of Papers American Chemical Society 219(1-2): MEDI 254
Pitts, L.; Symes, A. 1999: CNTF and TGF-beta pathways synergize through the VIP CyRE by activating SMAD and STAT transcription factors. Society for Neuroscience Abstracts 25(1-2): 1698
Wang, Q.; Peterson, W.M.; Tzekova, R.; Wiegand, S.J. 2000: CNTF and stress conditioning activate the Jak-STAT signaling pathway in rat retina. IOVS Investigative Ophthalmology and Visual Science 41(4): S21
So, K.; Zeng, Q.R.; Yip, H.K.; Cho, K.S. 1999: CNTF induced axonal re-growth across the crush site of the optic nerve. IOVS Investigative Ophthalmology and Visual Science 40(4): S267
Terheggen, U.; Kirsch, M.; Sendtner, M.; Hofmann, H.D. 2000: CNTF is an early lesion-induced retrograde signal for axotomized facial motoneurons. European Journal of Neuroscience 12(Suppl 11): 2
Levison, S.W.; Albrecht, P.J.; Murtie, J.C.; Ness, J.K.; Redwine, J.M.; Armstrong, R.C. 2002: CNTF is up-regulated in astrocytes during spinal cord remyelination and stimulates FGF-2 production. Journal of Neurochemistry 81(Suppl 1): 49
So, K.F.; Ji, J.; Elyaman, W.; Hugon, J.; Yip, H.K.; Lee, V.W.H. 2001: CNTF promotes the survival of cells in the retinal ganglion cell layer by inhibiting apoptosis in a rat glaucoma model. IOVS Investigative Ophthalmology and Visual Science 42(4): S24
Linker, R.A.; Gaupp, S.; Holtmann, B.; Toyka, K.V.; Lassmann, H.; Sendtner, M.; Gold, R. 2001: CNTF-deficiency deteriorates clinical course and histopathology in a murine model of experimental autoimmune encephalomyelitis A neurotrophic factor as outcome determinator of neuroinflammation. Neurology 56(8 Suppl 3): A67
Ngo, C.; Tawadros, R.; Mccabe, F.; Millar, H.; Nakada, M.; Anderson, G.M. 2003: CNTO 859, a humanized anti-tissue factor monoclonal antibody, inhibits lung metastasis and tumor growth in MDA-MB-231 breast cancer xenograft models. Pathophysiology of Haemostasis and Thrombosis 33(Suppl 1): 71
Nakada, M.T.; Yadav, R.; Trikha, M.; Nourshargh, S. 2003: CNTO 95, a novel human anti-alphavbeta3/alphavbeta5 antibody demonstrates anti-inflammatory activity by inhibiting leukocyte transmigration in vivo. Proceedings of the American Association for Cancer Research Annual Meeting 44: 603
Yadav, R.; Nakada, M.; Nourshargh, S. 2003: CNTO 95, a novel human anti-alphavbeta3/alphavbeta5 antibody, and 7E3, the parent molecule of Abciximab, exhibit comparable inhibitory effects on leukocyte transmigration in vivo. FASEB Journal 17(4-5): Abstract 758
Chiu, P.; Deldin, P.J.; Ambady, N. 2000: CNV response to emotional in- and out-group stimuli. Psychophysiology 37(Suppl 1): S32
Kallmark, F.P.; Carle Petrelius, B. 2001: CNV-treatment with PDT. IOVS Investigative Ophthalmology and Visual Science 42(4): S439
Choi, Y.D.; Park, J.A.; Rha, K.H.; Lee, M.S.; Mah, S.Y.; Choi, H.K. 2000: CO and NO in animal penile erection Physiologic, immunohistochemical and androgen regulatory study. Journal of Urology 163(4 Suppl): 196
Patskovska, L.N.; Patskovsky, Y.V.; Almo, S.C.; Hirsch, R.E.ison 2004: CO hemoglobin C and CO hemoglobin S crystallize in the R2 quaternary state at neutral pH in the presence of PEG 4000. Biophysical Journal 86(1): 247a
Ishida, Y.; Nakamoto, H.; Yamanouchi, Y.; Imai, H.; Suzuki, S.; Okano, H.; Sucmatsu, M.; Suzuki, H. 1999: CO produced water diuresis with suppression of expression of aquaporin. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 17A
Balabanova, L.; Sullivan, C.D.; Wang, X.; Fedinec, A.; Waters, C.M.; Leffler, C.W. 2002: CO production by newborn pig cerebral microvessels and endothelial cells. FASEB Journal 16(5): A846
Hu, R.B.; Boxer, S.G. 1999: CO recombination kinetics of sperm whale myoglobin mutants H93G and H64V/H93G as a function of proximal ligand L. Biophysical Journal 76(1 Part 2): A102
Carraway, M.S.; Ghio, A.J.; Carter, J.G.; Whorton, A.R.; Piantadosi, C.A. 2000: CO remodels pulmonary vessels in hypoxia. Acta Haematologica (Basel) 103(Suppl 1): 66
Maddock, M.; Bean, P.; Loomis, C.; Mammel, J.; Timmel, P.; Campbell, T.; Weltzin, T. 2004: CO-MORBID psychopathology and personality traits of males with eating disorders. Journal of Addictive Diseases 23(2): 155
Doll, A.; Aumueller, G.; Albrecht, M.; Song, J.; Tang, D. 2004: CO-localization studies of secretory and nonsecretory proteins in the developing, mature and senescent prostate. Journal of Andrology (Suppl S): 80
Haanstra, K.; Berkhoff, F.; Jonker, M. 2001: CO-stimulation blockade of xenoreactive human and monkey lymphocytes. Xenotransplantation 8(Suppl 1): 50
Morimoto, T.; Fuji, K.; Tsutsumi, K.; Kakiuchi, K. 2002: CO-transfer carbonylation reactions. a catalytic Pauson-Khand-type reaction of enynes with aldehydes as a source of carbon monoxide. Journal of the American Chemical Society 124(15): 3806-3807
Veawab, A.; Aroonwilas, A.; Tontiwachwuthikul, P. 2002: CO2 absorption performance of aqueous alkanolamines in packed columns. Abstracts of Papers American Chemical Society 223(1-2): FUEL 51
Brogan, T.V.; Robertson, H.T.; Lamm, W.; Souders, J.; Swenson, E.R. 2002: CO2 added to the latter half of inspiration improves ventilation-perfusion matching without accompanied respiratory acidosis. Pediatric Research 51(4 Part 2): 49A-50A
Salamon Albert, E. 2000: CO2 alphaexchange features of spring and summer herbs in submediterranean beech forests. Plant Physiology and Biochemistry 38: s132
Baligar, V.C.; Bunce, J.A. 2003: CO2 and light intenstiy effects on growth and nutrition of cacao. HortScience 38(5): 811
Monson, R.K.; Rawsthorne, S. 2000: CO2 assimilation in C3-C4 intermediate plants. Leegood, Richard C , Reprint Author, Sharkey, Thomas D, von Caemmerer, Susanne, Kennedy, Robert, Author Photosynthesis: Physiology and metabolism: 533-550
Cowan, R.M.; Ge, J.-J.; Qin, Y.-J.; McGregor, M.L.; Trachtenberg, M.C.; Trachtenberg, M.C. 2003: CO2 capture by means of an enzyme-based reactor. Annals of the new York Academy of Sciences 984: 453-469
Siriwardane, R.V.; Shen, M.; Fisher, E.; Poston, J. 2002: CO2 capture utilizing solid sorbents. Abstracts of Papers American Chemical Society 223(1-2): FUEL 106
Nattie, E.E.; Li, A.; Shi, J.; Swan, J. 2001: CO2 dialysis in the rostral part of the nucleus tractus solitarius of the unanesthetized rat produces a small increase in ventilation. FASEB Journal 15(4): A150
Lea, P.J.; Kiirats, O.; Edwards, G.E. 2001: CO2 diffusion resistance of bundle sheath cells in Amaranthus edulis, as revealed from the study of a PEP carboxylase deficient mutant. Photosynthesis Research 69(1-3): 150-151
Morini, S.; Melai, M. 2004: CO2 dynamics and growth in photoautotrophic and photomixotrophic apple cultures. Biologia Plantarum 47(2): 167-172, 2003-
Lubman, R.L.; Zheng, J.; Crandall, E.D. 2000: CO2 efflux across the apical membrane of alveolar epithelial cells is enhanced by extracellular carbonic anhydrase. FASEB Journal 14(4): A609
Kasurinen, A.; Holopainen, J.K.; Vapaavuori, E.; Holopainen, T. 2000: CO2 efflux from the rhizosphere soil of CO2- and O3-exposed silver birches. Plant Physiology and Biochemistry 38: s264
CantuSilva,I.; GonzalezRodriguez,H.; GomezMeza,M.V. 2010: CO2 efflux in vertisol under different land use systems. Tropical And Subtropical Agroecosystems: 2, 389-403
Kasai, H. 2002: CO2 electrochemical separation by molten carbonate technology. Abstracts of Papers American Chemical Society 223(1-2): FUEL 78
Pettersson,K.; Harvey,S. 2010: CO2 emission balances for different black liquor gasification biorefinery concepts for production of electricity or second-generation liquid biofuels. Energy (oxford): 2, 1101-1106
Souza,L.; Belote,R.T.; Kardol,P.; Weltzin,J.F.; Norby,R.J. 2010: CO2 enrichment accelerates successional development of an understory plant community. Journal Of Plant Ecology: 1, 33-39
Vu, J.C.; Allen, L.H. 2001: CO2 enrichment delays the adverse effects of severe drought on C4 sugarcane photosynthesis. Plant Biology (Rockville) : 95
Norby, R.J.; O'neill, E.G.; Gunderson, C.A.; Hanson, P.J. 2001: CO2 enrichment increases net primary productivity but not biomass increment in a closed-canopy forest stand. Ecological Society of America Annual Meeting Abstracts 86: 168
Liu, K.; Thomas, P.; Forse, R.A. 1999: CO2 exposure decreases colon cancer cell adhesion and macrophage-mediated cytotoxicity in vitro. Proceedings of the American Association for Cancer Research Annual Meeting 40: 448
Bailey, J.M.; Fedo, C.M. 2000: CO2 fixation and homochirality in an RNA world Biogeochemical evidence. Biochemical Society Transactions 28(5): A184
Parsons, A.N.; Barrett, J.E.; Blecker, S.W.; Catapano, K.G.; Porazinska, D.L.; Virginia, R.A.; Wall, D.H. 2001: CO2 flux from Antarctic Dry Valley soils Cross valley comparisons and relationship to soil biota. Ecological Society of America Annual Meeting Abstracts 86: 174
Tohidi, B.; Yang, J.; Salehabadi, M.; Anderson, R.; Chapoy, A. 2010: CO2 hydrates could provide secondary safety factor in subsurface sequestration of CO2. Environmental Science and Technology 44(4): 1509-1514
Park, Y.K.; Baek, S.W.; Ihm, S.K. 2002: CO2 hydrogenation over copper-based hybrid catalysts for the synthesis of oxygenates. Abstracts of Papers American Chemical Society 223(1-2): FUEL 135
Kircher, S.M.; Cote, R.J.; Dick, N.K.; Seip, W.F. 2000: CO2 incubation of MacConkey agar. Abstracts of the General Meeting of the American Society for Microbiology 100: 194
Pete, G.M.; Walbaum, S.B.; Haxhiu, M.A.; Gauda, E.B. 2000: CO2 induced c-Fos expression in tachykinin peptide containing brainstem neurons. FASEB Journal 14(4): A781
Moeller, M.; Schaefer, T.; Schlaefke, M.E. 2002: CO2 influences pupil fluctuations. Pfluegers Archiv European Journal of Physiology 443(Suppl 1): S363
Jackson, F.W. 2001: CO2 is easy. American Journal of Gastroenterology 96(10): 3035-3036
Sawatsubashi, M.; Inokuchi, A.; Fukaura, J.; Tokumaru, S.; Shin, T. 2002: CO2 laser surgery and radiotherapy in combination for early glottic carcinoma. International Journal of Cancer Suppl (13): 255
Torres, R.; Turner, D.; Rutllant, J.; Sobarzo, M.; Antezana, T.; Gonzalez, H.E. 2002: CO2 outgassing off central Chile and northern Chile during austral summer 1997 The effect of wind intensity on the upwelling and ventilation of CO2-rich waters. Deep-Sea Research Part I Oceanographic Research Papers 49(8): 1413-1429
Poulose, B.K.; Kutka, M.F.; Mendoza Sagaon, M.; Hardacre, J.M.; Murata, K.; Toung, T.J.; Talamini, M.A. 1999: CO2 pneumoperitoneum increases central nervous system blood flow during laparoscopic Nissen fundoplication. Gastroenterology 116(4 Part 2): A1342
Shah, P.C.; Wong, Y.T.; Birkett, D.H.; Brams, D.M. 1999: CO2 pneumoperitoneum reduces peritoneal and bowel serosal pH in a controlled porcine model. Gastroenterology 116(4 Part 2): A1352-A1353
Kuck, K.; Orr, J.A.; Haryadi, D.G.; Mcjames, S.; Westenskow, D.R. 1999: CO2 production is not a good surrogate cardiac output indicator. Anesthesiology 91(3A): A550
Peracchia, C.; Chen, J.T.; Peracchia, L.L. 2004: CO2 reduces the sensitivity of Cx40 channels to transjunctional voltage. Biophysical Journal 86(1): 583a-584a
Okada, Y.; Kuwana, S.; Chen, Z. 1999: CO2 response of the neurons in the ventromedial medulla of the rat. Society for Neuroscience Abstracts 25(1-2): 279
Soong, Y.; Jones, R.J.; Hedges, S.W.; Knoer, J.P.; Thompson, R.J.; Harrison, D.K.; Baltrus, J.P. 2002: CO2 sequestration using brines. Abstracts of Papers American Chemical Society 223(1-2): FUEL 49
Charney, A.N.; Egnor, R.W.; Cassai, N.D.; Sidhu, G.S. 2000: CO2 stimulates colonic Na+ absorption by affecting NHE-3 vesicular traffic. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A597
Hempleman, S.C. 1999: CO2 transduction in avian intrapulmonary chemoreceptors A dynamic balancing act. FASEB Journal 13(5 Part 2): A1093
Campagna, J.A.; Shank, E.; Denman, W.T. 2001: CO2 via CPAP mask? a near disaster. Anesthesiology 94(3): 544-545
Liger-Belair, G.ér.; Villaume, S.; Cilindre, C.; Jeandet, P. 2010: CO2 volume fluxes outgassing from champagne glasses: the impact of champagne ageing. Analytica Chimica Acta 660(1-2): 29-34
Hayashi, F.; Kato, T.; Fukuda, Y. 1999: CO2 vs respiratory motor output in an in vivo newborn rat. FASEB Journal 13(4 Part 1): A165
O'Keefe, J.M.K.; Henke, K.R.; Hower, J.C.; Engle, M.A.; Stracher, G.B.; Stucker, J.D.; Drew, J.W.; Staggs, W.D.; Murray, T.M.; Hammond, M.L.; Adkins, K.D.; Mullins, B.J.; Lemley, E.W. 2010: CO(2), CO, and Hg emissions from the Truman Shepherd and Ruth Mullins coal fires, eastern Kentucky, USA. Science of the Total Environment 408(7): 1628-1633
Nattie, E. 1999: CO2, brainstem chemoreceptors and breathing. Progress in Neurobiology 59(4): 299-331
Mokashi, A.; Roy, A.; Rozanov, C.; Lahiri, S. 1999: CO2-O2 stimulus interaction causes parallel changes in i of glomus cells and neural discharge of the rat carotid body. FASEB Journal 13(5 Part 2): A1110
Levis, S. 2002: CO2-climate-vegetation interactions at the LGM as simulated by a coupled climate-vegetation model. Ecological Society of America Annual Meeting Abstracts 87: 33
Diaz, G.; Isola, R.; Falchi, A.M.; Diana, A. 1999: CO2-enriched atmosphere on the microscope stage. Biotechniques 27(2): 292-294
Zhou, Y.ehan; Bouyer, Patrice; Boron, Walter, F. 2003: CO2-evoked increase in HCO3 reabsorption in the rabbit S2 proximal tubule blockade by genistein. FASEB Journal 17(4-5): Abstract 802
Gitel'zon, I.I.; Tikhomirov, A.A.; Kalacheva, G.S.; Ushakova, S.A.; Parshina, O.V. 1999: CO2-exchange and volatile emission by radish cenosis under elevated temperatures. Doklady Akademii Nauk 369(3): 408-410
Yamaguchi, S.; Takahashi, T.; Funahashi, Y.; Jitsukawa, K.; Masuda, H. 2003: CO2-fixation mediated upon zinc-hydroxo complex containing amino group. Journal of Inorganic Biochemistry 96(1): 253, 15 July
Iglesias, L.; Benitez, R.; Valero, A.; Adroher, F.J. 1999: CO2-fixing enzyme activities during the Anisakis simplex ss M3 ecdysis. American Journal of Tropical Medicine and Hygiene 61(3 Suppl): 261
Iglesias, L.; Benitez, R.; Valero, A.; Adroher, F.J. 2000: CO2-fixing enzyme activities during the third to fourth stage larvae moulting of the Hysterothylacium aduncum. American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 294-295
Gupta, A.; Dimmel, B.C. 2003: CO2-hydrate product and method of manufacture thereof. Official Gazette of the United States Patent and Trademark Office Patents 1271(2)
Nakajima, S.; Aoyama, Y.; Takahashi, R. 2002: CO2-monitoring urea breath test: An ideal method for collecting expiratory breath using a real-time CO2 monitor. Gastroenterology 122(4 Suppl 1): A-208
Blank, M.E.; Ehmke, H. 2001: CO2-transport across the human erythrocyte membrane. Pfluegers Archiv European Journal of Physiology 441(6 Suppl): R250
Tisserat, B.; Silman, R. 2000: CO2-ultrasonic fogging system enhances tissue culture shoot survival and growth. HortScience 35(3): 450
Solomon, I.C.; O'neal, M.H.IIi; Edelman, N.H. 1999: CO2/H+-chemosensitivity of the pre-Botzinger complex in vivo. FASEB Journal 13(4 Part 1): A164
Overholt, J.L.; Summers, B.A.; Prabhakar, N.R. 2002: CO2/HCO3- modulates HERG K+ and Ca2+ current Implications for sensory transduction in the carotid body. FASEB Journal 16(4): A62-A63
Perry, S.; Gilmour, K. 2001: CO2/pH chemoreception in fish Fact or artifact?. FASEB Journal 15(4): A152
Branco,D.A.C.; Szklo,A.S.; Schaeffer,R. 2010: CO2e emissions abatement costs of reducing natural gas flaring in Brazil by investing in offshore GTL plants producing premium diesel. Energy (oxford): 1, 158-167
Meza Zepeda, L.A.; Forus, A.; Dahlberg, A.B.; Godager, L.H.; Marenholz, I.; South, A.; Nizetic, D.; Lioumi, M.; Ragoussis, I.; Serra, M.; Myklebost, O. 2001: COAS1, -2 and -3, three candidate genes for amplification in 1q21, a region frequently amplified in human malignancies. Proceedings of the American Association for Cancer Research Annual Meeting 42: 191
Dyer, N.H.C.; Ohhashi, Y.; Lowery, J.D.; Hwang, A.Y.; Morid, M.; Nguyen, M.D.; Thomas, P.; Lamendola, M.H.; Gallarda, J.L. 2002: COBAS Ampli ScreenTM PCR System contamination control study using HIV-1 AIDS and asymptomatic specimens. Vox Sanguinis 83(Suppl 2): 38
Tsang, S.; Patten, N.; Birkett, J.; Kauffman, L.; Chan, L.; Demartin, K.; Kuo, M.; Muller, M.; Kwok, S.; Gutekunst, K.; Wu, P. 1999: COBAS TaqMan HCV MONITORTM Test. Journal of Hepatology 30(Suppl 1): 264
Roudier, F.; Fernandez, A.; Benfey, P.N. 2003: COBRA, a GPI-anchored membrane protein, regulates anisotropic cell expansion during Arabidopsis development. Developmental Biology 259(2): 586
Cui, H. 2003: COC166-9 and 6B11. Hybridoma and Hybridomics 22(3): 187-190
Singer, S.R.; Anderson, I.A.; Sydney, C.N.; Mckittrick, E.K. 1999: COCHLEATA links development of leaves, flowers, and asymmetry in pea. Developmental Biology 210(1): 208
Takeda, S.I.; Yu, S.J.; Nishizaki, Y.; Nishijima, S.; Izumi, Y.; Ema, K. 2003: COD reduction of the wastedwater from paper manufacturing process using magnetic separation. Abstracts of Papers American Chemical Society 225(1-2): IEC 262
Williams, R.R. 2000: CODE-2* An opportunity to compare costs and management of people with type 2 diabetes in UK and the USA?. Diabetes Research and Clinical Practice 50(Suppl 1): S191
Tubbs, R.R.; Pettay, J.; Roche, P.; Stoler, M.; Jenkins, R.; Myles, J.; Grogan, T. 2000: CODFISH Simultaneous assessment of Her-2/neu oncogene amplification and encoded protein expression. Laboratory Investigation 80(1): 226A
Park, D. Kim, J.S.; Cho, D.S.; Lim, P.O.; Nam, H.G. 2002: COG1, a negative regulator of phyA and phyB dependent responses in Arabidopsis. Plant Biology (Rockville) : 112
Merlotti, C.; Riba Garcia, I.; Gaskell, S.J.; Yin, Z.; Brown, A.; Cash, P.; Hayes, A.; Talbot, N.J.; Brass, A.; Paton, N.; Oliver, S.G. 2003: COGEME-Consortium for the functional genomics of microbial eukaryotes Facilities for the functional analysis of microbial genomes. Yeast 20(Suppl 1): S341
Suematsu, M. 2002: COHb: a stress-induced marker reflecting surgical insults?. Journal of Gastroenterology and Hepatology 17(5): 519-520
Li, Y.; Zhou, X.; Feng, G.; Hu, H.; Niu, L.; Hebert, P.D.N.; Huang, D. 2010: COI and ITS2 sequences delimit species, reveal cryptic taxa and host specificity of fig-associated Sycophila (Hymenoptera, Eurytomidae). Molecular Ecology Resources 10(1): 31-40
Prais, D.; Merlob, P.; Horev, G. 2002: COIF syndrome: the diversity of clinical and radiological findings. American Journal of Medical Genetics 107(2): 179-180
Green, L.K.; Cabral, W.A.; Fertala, A.; Korkko, J.; Forlino, A.; Marini, J.C. 2000: COL1A1 IVS A+4 C mutation causes splicing out of exon 41 and confirms importance of this region for fibril self-assembly. American Journal of Human Genetics 67(4 Suppl 2): 369
Macdonald, H.M.; Mcguigan, F.E.; New, S.A.; Golden, M.H.; Ralston, S.A.; Reid, D.M. 1999: COL1A1 polymorphism and change in bone density over 5 years Findings from a longitudinal study of bone health in Scottish peri- and recent post-menopausal women. Journal of Bone and Mineral Research 14(Suppl 1): S458
Bei, T.A.; Tilkeridis, C.; Garatziotis, S.; Kortesas, E.; Stratakis, C.A. 2002: COL1A1 polymorphism in young male Greek army recruits with lumbar disk disease. American Journal of Human Genetics 71(4 Suppl): 467
Hashimoto, H.; Wang, J.; Morimitsu, Y.; Hisaoka, M.; Ishida, T. 2000: COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by RT-PCR using archival paraffin-embedded tissues. Laboratory Investigation 80(3): 10A
Maire, G.; Pedeutour, F.; Mrózek, K.; Ryś, J.; Iliszko, M.; Limon, J. 2002: COLIA1-PDGFB gene fusion in dermatofibrosarcoma protuberans. molecular analysis of a case with an unusual large marker containing sequences from chromosomes 7, 8, 17, 21, and 22. Cancer Genetics and Cytogenetics 135(2): 197-199
Pals, G.; Keek, J.M.F.; Van Den Akker, E.; Blok, B.; Cobben, J.M. 2000: COL3A1 mutations in 5 EDS IV patients with normal collagen III electrophoresis, found by enzyme mismatch detection. European Journal of Human Genetics 8(Suppl 1): 73
Watanabe, A.; Sakai, N.; Wada, T.; Fujimoto, M.; Fukushima, Y.; Shimada, T. 2003: COL3A1 mutations in Japanese patients with Ehlers-Danlos syndrome type IV. American Journal of Human Genetics 73(5): 554
Gross, O.; Netzer, K.O.; Lambrecht, R.; Seibold, S.; Weber, M. 2002: COL4A4 splice defect and in-frame deletion in a large family as a molecular-genetic link between Benign Familial Hematuria and Alport Syndrome. Pathology Research and Practice 198(3): 203
Stewart, T.L.; Roschger, P.; Grabner, B.; Fratzl, P.; Mann, V.; Aspden, R.M.; Klaushofer, K.; Ralston, S.H. 2002: COLIA1 Sp1 binding site polymorphism predisposes to osteoporotic fractures by altering collagen production and impairing bone mineralisation. Calcified Tissue International 70(4): 255
Mcguigan, F.E.A.; Stewart, A.; Reid, D.; Ralston, S.H. 2000: COLIA1 Sp1 polymorphism and quantitative ultrasound parameters of bone in early postmenopausal women. Calcified Tissue International 67(6): 496
Weichetova, M.; Stepan, J.; Michalska, D.; Haas, T. 2000: COLIA1 Sp1 polymorphism is associated with an increased risk of wrist fracture in postmenopausal women. Calcified Tissue International 67(6): 490
Semenov,A.V.; Franz,E.; Bruggen,A.H.C.van 2010: COLIWAVE a simulation model for survival of E coli O157H7 in dairy manure and manure-amended soil. Ecological Modelling 1(4): 599-609
Lutchmedial, S.; Reeves, F.; Martin, M.; Gagnon, R.M.; Leclerc, G.; Rivard, A. 2000: COMBO pilot trial Combined revascularization with stenting by radial approach and minimally invasive internal mammary bypass grafting compared to classical CABG 1 year angiographic follow-up. European Heart Journal 21(Abstract Suppl): 612
Muzic, R.F.; Cornelius, S.; Zhang, Z. 2000: COMKAT Compartmental model kinetic analysis tool. Journal of Nuclear Medicine 41(5 Suppl): 189P
Holden, P.; Newman, W.; Jones, C.J.P.; Grant, M.E.; Briggs, M.D. 1999: COMP gene mutations result in abnormal collagen fibril morphology. American Journal of Human Genetics 65(4): A301
Grunewald, M.; Schrauder, M.; Mueller, S.; Neuhuber, W.L.; Kirchner, T.; Bautz, W.A. 2000: COMPARE Web-based training in Anatomy, Radiology and Pathology at the University of Erlangen-Nuernberg. Pathology Research and Practice 196(6): 457
Kanes, S.J.; Sawires, A.; Krenzler, H.; Malison, R.R.; Price, L.H.L.H.; Berman, R.; Ichinose, H.; Nagatsu, T.; Wantroba, A.M.; Rosenheck, R.; Kramer, J.; Charney, D.; Gelemter, J. 1999: COMT Population and association studies of a functional polymorphism. Society for Neuroscience Abstracts 25(1-2): 2094
Taerk, E.; Grizenko, N.; Ben Amor, L.; Lageix, P.; Mbekou, V.; Deguzman, R.; Torkmanzahi, A.; Ter Stepaninan, M.; Baron, C.; Joober, R. 2003: COMT Val108/158 Met polymorphism does not modulate executive functions in children with ADHD. American Journal of Medical Genetics 122B(1): 56
Goldman, D.; Heitzeg, M.M.; Smith, Y.R.; Bueller, J.A.; Xu, K.; Xu, Y.; Koeppe, R.A.; Stohler, C.S.; Zubieta, J. 2003: COMT Val158Met Linkage to pain/stress response, anxiety, and cognition. Alcoholism Clinical and Experimental Research 27(5 Suppl): 9A
Goldman, D.; Malhotra, A.; Egan, M.; Kolachana, B.; Warden, D.; Lipsky, R.H.; Salazar, A.M.; Xu, K.; Goldberg, T.; Weinberger, D. 2001: COMT Val158Met and cognitive executive function. American Journal of Human Genetics 69(4 Suppl): 562
Goldman, D.; Malhotra, A.; Egan, M.; Kolachana, B.; Warden, D.; Lipsky, R.; Salazar, A.M.; Xu, K.; Goldberg, T.; Weinberger, D. 2001: COMT Val158Met and prefrontal cognitive function Genetic analysis using intermediate phenotype and candidate allele. Alcoholism Clinical and Experimental Research 25(5 Suppl A): 68A
D.B.lla, D.; Deckert, J.; Martin Santos, R.; Franke, P.; Gratacos, M.; Fritze, J.; Garritsen, H.; Perna, G.; Perez, G.; Nothen, M.M.; Cucchi, M.; Armengol, L.; Bulbena, A.; Estivill, X.; Arolt, V.; Bellodi, L.; Catalano, M. 2002: COMT gene Lessons from panic disorder for association studies in psychiatry. American Journal of Medical Genetics 114(7): 795
Rosa, A.; Zarzuela, A.; Cuesta, M.J.; Peralta, V.; Martinez Larrea, A.; Serrano, F.; Fananas 2002: COMT gene variability and prefrontal neurocognitive functions in discordant sib pairs for schizophrenia spectrum disorders. American Journal of Medical Genetics 114(7): 867
Xu, K.; Mangal, W.; Nagarajan, S.; Ferro, E.; Liu, X.H.; Goldman, D. 2001: COMT haplotype relative risk for substance dependence in four populations. American Journal of Human Genetics 69(4 Suppl): 403
Sand, P.; Eichhammer, P.; Putzhammer, A.; Albus, M.; Wildenauer, D.; Borrmann Hassenbach, M.; Schwab, S.; Dallinger, P.; Langguth, B.; Hajak, G. 2003: COMT haplotypes in schizophrenia. European Neuropsychopharmacology 13(Suppl 4): S452
Storch, A.; Blessing, H.; Bareiss, M.; Jankowski, S.; Schwarz, J. 1999: COMT inhibitors attenuate levodopa toxicity in primary dopaminergic neurons Mechanisms of action. Society for Neuroscience Abstracts 25(1-2): 334
Alsobrook, J.P.; Zohar, A.H.; Leboyer, M.; Chabane, N.; Ebstein, R.P.; Pauls, D.L. 1999: COMT is not associated with Obsessive Compulsive Disorder Family-based vs population-based designs. American Journal of Human Genetics 65(4): A263
Odlind, C.; Mannisto, P.T.; Reenila, I.; Gogos, J.A.; Karayiorgou, M.; Hansell, P. 2000: COMT knock-out mice show reduced renal sodium excretion after volume expansion. Acta Physiologica Scandinavica 170(4): A97-A98
Goodman, J.E.; He, P.; Yager, J.D. 2002: COMT polymorphism and catechol estrogen methylation in breast epithelial cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 43: 692